{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:39:00Z","timestamp":1790199540068,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":393,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811376467","type":"print"},{"value":"9789811376474","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7647-4_9","type":"book-chapter","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:56:47Z","timestamp":1569891407000},"page":"407-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Contributions of Drug Transporters to Blood-Brain Barriers"],"prefix":"10.1007","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1007074420772","volume":"20","author":"NJ Abbott","year":"2000","unstructured":"Abbott NJ (2000) Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20:131\u2013147","journal-title":"Cell Mol Neurobiol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1208\/s12248-017-0081-9","volume":"19","author":"W Abdullahi","year":"2017","unstructured":"Abdullahi W, Davis TP, Ronaldson RT (2017) Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood-brain barrier: understanding transport mechanisms for improved CNS drug delivery? AAPS J 19:931\u2013939","journal-title":"AAPS J"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1021\/cn300077c","volume":"3","author":"AH Abuznait","year":"2012","unstructured":"Abuznait AH, Kaddoumi A (2012) Role of ABC transporters in the pathogenesis of Alzheimer\u2019s disease. ACS Chem Neurosci 3:820\u2013831","journal-title":"ACS Chem Neurosci"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/cn400024q","volume":"4","author":"AH Abuznait","year":"2013","unstructured":"Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A (2013) Olive-oil-derived oleocanthal enhances \u03b2-amyloid clearance as a potential neuroprotective mechanism against Alzheimer\u2019s disease: in vitro and in vivo studies. ACS Chem Neurosci 4:973\u2013982","journal-title":"ACS Chem Neurosci"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1124\/jpet.110.167601","volume":"334","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Sane R, Gallardo JL, Ohlfest JR, Elmquist WF (2010) Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux. J Pharmacol Exp Ther 334:147\u2013155","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/jpet.110.175034","volume":"336","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Sane R, Ohlfest JR, Elmquist WF (2011a) The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain. J Pharmacol Exp Ther 336:223\u2013233","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.2174\/138161211797440186","volume":"17","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Hartz AMS, Elmquist WF, Bauer B (2011b) Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des 17:2793\u20132802","journal-title":"Curr Pharm Des"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1124\/dmd.112.044719","volume":"40","author":"S Agarwal","year":"2012","unstructured":"Agarwal S, Uchida Y, Mittapalli RK, Sane R, Terasaki T, Elmquist WF (2012) Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-GP), breast cancer resistance protein (Bcrp), and P-GP\/Bcrp knockout mice. Drug Metab Dispos 40:1164\u20131169","journal-title":"Drug Metab Dispos"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jnc.12939","volume":"132","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal A, Khera A, Singh I, Sandhir R (2015) S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes. J Neurochem 132:595\u2013608","journal-title":"J Neurochem"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2016.07.041","volume":"368","author":"SSSJ Ahmed","year":"2016","unstructured":"Ahmed SSSJ, Husain RSA, Kumar S, Ramakrishnan V (2016) Association between MDR1 gene polymorphisms and Parkinson\u2019s disease in Asian and Caucasian populations: a meta-analysis. J Neurol Sci 368:255\u2013262","journal-title":"J Neurol Sci"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neuint.2007.12.002","volume":"52","author":"S Akanuma","year":"2008","unstructured":"Akanuma S, Ohtsuki S, Doi Y, Tachikawa M, Ito S, Hori S et al (2008) ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1\u221240) at the blood-brain barrier. Neurochem Int 52:956\u2013961","journal-title":"Neurochem Int"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1124\/jpet.109.165332","volume":"333","author":"S Akanuma","year":"2010","unstructured":"Akanuma S, Hosoya K, Ito S, Tachikawa M, Terasaki T, Ohtsuki S (2010) Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. J Pharmacol Exp Ther 333:912\u2013919","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2045-8118-8-24","volume":"8","author":"S Akanuma","year":"2011","unstructured":"Akanuma S, Uchida Y, Ohtsuki S, Tachikawa M, Terasaki T, Hosoya K (2011) Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole. Fluids Barriers CNS 8:24","journal-title":"Fluids Barriers CNS"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/jcbfm.2010.148","volume":"31","author":"A Ahmad Al","year":"2011","unstructured":"Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO (2011) Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab 31:693\u2013705","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1212\/WNL.57.7.1282","volume":"57","author":"ME Alexianu","year":"2001","unstructured":"Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282\u20131289","journal-title":"Neurology"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1600-0404.2007.00823.x","volume":"115","author":"A Algotsson","year":"2007","unstructured":"Algotsson A, Winblad B (2007) The integrity of the blood-brain barrier in Alzheimer\u2019s disease. Acta Neurol Scand 115:403\u2013408","journal-title":"Acta Neurol Scand"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1463-1326.2008.00987.x","volume":"11","author":"CL Allen","year":"2009","unstructured":"Allen CL, Bayraktutan U (2009) Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability. Diabetes Obes Metab 11:480\u2013490","journal-title":"Diabetes Obes Metab"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","volume":"50","author":"A Amphoux","year":"2006","unstructured":"Amphoux A, Vialou V, Drescher E, Br\u00fcss M, Mannoury La Cour C, Rochat C, Millan MJ et al (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in at brain. Neuropharmacology 50:941\u2013952","journal-title":"Neuropharmacology"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2008.19.3789","volume":"27","author":"L Angelov","year":"2009","unstructured":"Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM (2009) Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol 27:3503\u20133509","journal-title":"J Clin Oncol"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","volume":"23","author":"O Arancio","year":"2004","unstructured":"Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D et al (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 23:4096\u20134105","journal-title":"EMBO J"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JAD-2009-1071","volume":"17","author":"GW Arendash","year":"2009","unstructured":"Arendash GW, Holtzman DM, Potter H (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer\u2019s disease transgenic mice. J Alzheimers Dis 17:681\u2013697","journal-title":"J Alzheimers Dis"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557\u2013561","journal-title":"Nature"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.0013-9580.2004.57703.x","volume":"45","author":"E Aronica","year":"2004","unstructured":"Aronica E, Gorter JA, Ramkema M, Redeker S, Oezbas-Gercerer F, van Vliet EA et al (2004) Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 45:441\u2013451","journal-title":"Epilepsia"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F (2005) Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222\u2013231","journal-title":"Acta Neuropathol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2007.01.013","volume":"257","author":"J Attems","year":"2007","unstructured":"Attems J, Quass M, Jellinger KA, Lintner F (2007) Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 257:49\u201355","journal-title":"J Neurol Sci"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.vph.2006.04.004","volume":"45","author":"AS Awad","year":"2006","unstructured":"Awad AS (2006) Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Vascul Pharmacol 45:141\u2013147","journal-title":"Vascul Pharmacol"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.11.007","volume":"14","author":"AL Bartels","year":"2008","unstructured":"Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, de Klerk O et al (2008a) Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson\u2019s disease. Parkinsonism Relat Disord 14:505\u2013508","journal-title":"Parkinsonism Relat Disord"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","volume":"115","author":"AL Bartels","year":"2008","unstructured":"Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R et al (2008b) Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA. Neural Transm (Vienna) 115:1001\u20131009","journal-title":"Neural Transm (Vienna)"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2045-8118-11-17","volume":"11","author":"CA Bates","year":"2014","unstructured":"Bates CA, Zheng W (2014) Brain disposition of \u03b1-Synuclein: roles of brain barrier systems and implications for Parkinson\u2019s disease. Fluids Barriers CNS 11:17","journal-title":"Fluids Barriers CNS"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","volume":"25","author":"DR Beers","year":"2011","unstructured":"Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A et al (2011) Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun 25:1025\u20131035","journal-title":"Brain Behav Immun"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.taap.2009.05.024","volume":"240","author":"M Behl","year":"2009","unstructured":"Behl M, Zhang Y, Monnot AD, Jiang W, Zheng W (2009) Increased \u03b2-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1. Toxicol Appl Pharmacol 240:245\u2013254","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuro.2010.05.004","volume":"31","author":"M Behl","year":"2010","unstructured":"Behl M, Zhang Y, Shi Y, Cheng J, Du Y, Zheng W (2010) Lead-induced accumulation of \u03b2-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 31:524\u2013532","journal-title":"Neurotoxicology"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1158\/0008-5472.CAN-06-2680","volume":"67","author":"MG Belinsky","year":"2007","unstructured":"Belinsky MG, Guo P, Lee K, Zhou F, Kotova E, Grinberg A (2007) Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. Cancer Res 67:262\u2013268","journal-title":"Cancer Res"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118:103\u2013113","journal-title":"Acta Neuropathol"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb1819","volume":"11","author":"RD Bell","year":"2009","unstructured":"Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I et al (2009) SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11:143\u2013153","journal-title":"Nat Cell Biol"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R et al (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68:409\u2013427","journal-title":"Neuron"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1208\/s12248-008-9018-7","volume":"10","author":"MA Bellavance","year":"2008","unstructured":"Bellavance MA, Blanchette M, Fortin D (2008) Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J 10:166\u2013177","journal-title":"AAPS J"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF01243407","volume":"53","author":"E Ben-Menachem","year":"1982","unstructured":"Ben-Menachem E, Johansson BB, Svensson TH (1982) Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline. J Neural Transm 53:159\u2013167","journal-title":"J Neural Transm"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/j.1471-4159.2007.04808.x","volume":"102","author":"S Bihorel","year":"2007","unstructured":"Bihorel S, Camenisch G, Lemaire M, Scherrmann JM (2007) Influence of breast cancer resistance protein (Abcg2) and P-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood\u2013brain barrier. J Neurochem 102:1749\u20131757","journal-title":"J Neurochem"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11060-008-9678-2","volume":"91","author":"JO Blakeley","year":"2009","unstructured":"Blakeley JO, Olson J, Grossman SA, He X, Weingart J, Supko JG (2009) Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study. J Neurooncol 91:51\u201358","journal-title":"J Neurooncol"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"2","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2:39\u201359","journal-title":"Neuron"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","volume":"114","author":"JA Boockvar","year":"2011","unstructured":"Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K et al (2011) Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg 114:624\u2013632","journal-title":"J Neurosurg"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.expneurol.2008.06.010","volume":"213","author":"W Boston-howes","year":"2008","unstructured":"Boston-howes W, Williams EO, Bogush A, Scolere M, Pasinelli P, Trotti D (2008) Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis. Exp Neurol 213:229\u2013237","journal-title":"Exp Neurol"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","volume":"68","author":"GL Bowman","year":"2007","unstructured":"Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF (2007) Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68:1809\u20131814","journal-title":"Neurology"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","volume":"24","author":"C Brandt","year":"2006","unstructured":"Brandt C, Bethmann K, Gastens AM, Loscher W (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24:202\u2013211","journal-title":"Neurobiol Dis"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/bpa.12069","volume":"24","author":"A Brenn","year":"2014","unstructured":"Brenn A, Grube M, Jedlitschky G, Fischer A, Strohmeier B, Eiden M et al (2014) St. John\u2019s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer\u2019s disease mouse model-role of P-glycoprotein. Brain Pathol 24:18\u201324","journal-title":"Brain Pathol"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","volume":"66","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth SD, Ludolph AC, Tumani H (2006) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66:852\u2013856","journal-title":"Neurology"},{"key":"9_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039216","volume":"7","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee VM et al (2012) Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One 7:e39216","journal-title":"PLoS One"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"H738","DOI":"10.1152\/ajpheart.01288.2004","volume":"289","author":"TA Brooks","year":"2005","unstructured":"Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP (2005) Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alteration. Am J Physiol Heart Circ Physiol 289:H738\u2013H743","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2006.08.085","volume":"1120","author":"TA Brooks","year":"2006","unstructured":"Brooks TA, Ocheltree SM, Seelbach MJ, Charles RA, Nametz N, Egleton RD et al (2006) Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res 1120:172\u2013182","journal-title":"Brain Res"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.critrevonc.2010.09.001","volume":"80","author":"C Buonerba","year":"2011","unstructured":"Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M et al (2011) A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit Rev Oncol Hematol 80:54\u201368","journal-title":"Crit Rev Oncol Hematol"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.wneu.2011.05.056","volume":"77","author":"JK Burkhardt","year":"2012","unstructured":"Burkhardt JK, Riina H, Shin BJ, Christos P, Kesavabhotla K, Hofstetter CP et al (2012) Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg 77:130\u2013134","journal-title":"World Neurosurg"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","volume":"23","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer\u2019s disease brain contribute to neuronal death. Neurobiol Aging 23:655\u2013664","journal-title":"Neurobiol Aging"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.brainres.2008.05.013","volume":"1221","author":"CR Campos","year":"2008","unstructured":"Campos CR, Ocheltree SM, Hom S, Egleton RD, Davis TP (2008) Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res 1221:6\u201313","journal-title":"Brain Res"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"15930","DOI":"10.1073\/pnas.1203534109","volume":"109","author":"RE Cannon","year":"2012","unstructured":"Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS (2012) Targeting blood brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc Natl Acad Sci USA 109:15930\u201315935","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1158\/0008-5472.CAN-09-4264","volume":"70","author":"AM Carcaboso","year":"2010","unstructured":"Carcaboso AM, Elmeliegy MA, Shen J, Juel SJ, Zhang ZM, Calabrese C et al (2010) Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas. Cancer Res 70:4499\u20134508","journal-title":"Cancer Res"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neurobiolaging.2013.09.015","volume":"35","author":"A Carrano","year":"2014","unstructured":"Carrano A, Snkhchyan H, Kooij G, van der Pol S, Horssen J, Veerhuis R et al (2014) ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy. Neurobiol Aging 35:565\u2013575","journal-title":"Neurobiol Aging"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jcbfm.2012.174","volume":"33","author":"TA Cartwright","year":"2013","unstructured":"Cartwright TA, Campos CR, Cannon RE, Miller DS (2013) Mrp1 is essential for sphingolipid signaling to P-glycoprotein in mouse blood\u2013brain and blood\u2013spinal cord barriers. J Cereb Blood Flow Metab 33:381\u2013388","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","volume":"22","author":"PM Carvey","year":"2005","unstructured":"Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS et al (2005) 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci 22:1158\u20131168","journal-title":"Eur J Neurosci"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/jphp.12033","volume":"65","author":"J Cen","year":"2013","unstructured":"Cen J, Liu L, Li MS, He L, Wang LJ, Liu YQ et al (2013) Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats. J Pharm Pharmacol 65:665\u2013672","journal-title":"J Pharm Pharmacol"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jtho.2015.10.021","volume":"11","author":"S Chakraborty","year":"2016","unstructured":"Chakraborty S, Filippi CG, Burkhardt JK, Fralin S, Ray A, Wong T et al (2016) Durability of single dose intra-arterial bevacizumab after blood\/brain barrier disruption for recurrent glioblastoma. J Exp Ther Oncol 11:261\u2013267","journal-title":"J Exp Ther Oncol"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2016.12.049","volume":"639","author":"GN Chan","year":"2017","unstructured":"Chan GN, Evans RA, Banks DB, Mesev EV, Miller DS, Cannon RE (2017) Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model. Neurosci Lett 639:103\u2013113","journal-title":"Neurosci Lett"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1014892706696","volume":"27","author":"JM Chehade","year":"2002","unstructured":"Chehade JM, Haas MJ, Mooradian AD (2002) Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem Res 27:249\u2013252","journal-title":"Neurochem Res"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1124\/jpet.109.154781","volume":"330","author":"Y Chen","year":"2009","unstructured":"Chen Y, Agarwal S, Shaik NM, Chen C, Yang Z, Elmquist WF (2009) P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib. J Pharmacol Exp Ther 330:956\u2013963","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2045-8118-11-25","volume":"11","author":"X Chen","year":"2014","unstructured":"Chen X, Loryan I, Payan M, Keep RF, Smith DE, Hammarlund-Udenaes M (2014) Effect of transporter inhibition on the distribution of cefadroxil in rat brain. Fluids Barriers CNS 11:25","journal-title":"Fluids Barriers CNS"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcp.2017.02.005","volume":"131","author":"X Chen","year":"2017","unstructured":"Chen X, Keep RF, Liang Y, Zhu HJ, Hammarlund-Udenaes M, Hu Y et al (2017) Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: a microdialysis study. Biochem Pharmacol 131:89\u201397","journal-title":"Biochem Pharmacol"},{"key":"9_CR70","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","volume":"36","author":"C Chiu","year":"2015","unstructured":"Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD (2015) P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer\u2019s disease: preliminary observations. Neurobiol Aging 36:2475\u20132482","journal-title":"Neurobiol Aging"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1096\/fj.08-126383","volume":"23","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ et al (2009) RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer\u2019s disease animal model. FASEB J 23:2639\u20132649","journal-title":"FASEB J"},{"key":"9_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.147","volume":"46","author":"BR Choi","year":"2014","unstructured":"Choi BR, Cho WH, Kim J, Lee HJ, Chung C, Jeon WK et al (2014) Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Mol Med 46:e75","journal-title":"Exp Mol Med"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"370526","DOI":"10.1155\/2013\/370526","volume":"2013","author":"YC Chung","year":"2013","unstructured":"Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK (2013) MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease. Mediators Inflamm 2013:370526","journal-title":"Mediators Inflamm"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB et al (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285\u20133290","journal-title":"J Clin Invest"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","volume":"64","author":"S Cisternino","year":"2004","unstructured":"Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann JM (2004) Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res 64:3296\u20133301","journal-title":"Cancer Res"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12015-017-9752-2","volume":"13","author":"GC Coatti","year":"2017","unstructured":"Coatti GC, Frangini M, Valadares MC, Gomes JP, Lima NO, Cava\u00e7ana N et al (2017) Pericytes extend survival of ALS SOD1 mice and induce the expression of antioxidant enzymes in the murine model and in IPSCs derived neuronal cells from an ALS patient. Stem Cell Rev 13:686\u2013698","journal-title":"Stem Cell Rev"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","volume":"289","author":"SP Cole","year":"2014","unstructured":"Cole SP (2014) Multidrug resistance protein 1 (MRP1, ABCC1), a \u201cmultitasking\u201d ATP-binding cassette (ABC) transporter. J Biol Chem 289:30880\u201330888","journal-title":"J Biol Chem"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","volume":"13","author":"HC Cooray","year":"2002","unstructured":"Cooray HC, Blackmore CG, Maskell L, Barrand MA (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13:2059\u20132063","journal-title":"Neuroreport"},{"key":"9_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052941","volume":"7","author":"P Corcia","year":"2012","unstructured":"Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J et al (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7:e52941","journal-title":"PLoS One"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/WCO.0b013e328341f8c0","volume":"24","author":"C Cordonnier","year":"2011","unstructured":"Cordonnier C (2011) Brain microbleeds: more evidence, but still a clinical dilemma. Curr Opin Neurol 24:69\u201374","journal-title":"Curr Opin Neurol"},{"key":"9_CR1000","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2014.09.008","volume":"146","author":"T Courouss\u00e9","year":"2015","unstructured":"Courouss\u00e9 T, Gautron S (2015) Role of organic cation transporters (OCTs) in the brain. Pharmacol Ther 146:94\u2013103. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.008","journal-title":"Pharmacol Ther"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0006-8993(02)03294-8","volume":"954","author":"JP Dai","year":"2002","unstructured":"Dai JP, Vrensen GFJM, Schlingemann RO (2002) Blood\u2013brain barrier integrity is unaltered in human brain cortex with diabetes mellitus. Brain Res 954:311\u2013316","journal-title":"Brain Res"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood brain barrier integrity during embryogenesis. Nature 468:562\u2013566","journal-title":"Nature"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1471-4159.2008.05720.x","volume":"107","author":"S Dauchy","year":"2008","unstructured":"Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO et al (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107:1518\u20131528","journal-title":"J Neurochem"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","volume":"13","author":"NA Vries de","year":"2007","unstructured":"de Vries NA, Zhao J, Kroon E, Buckle T, Beijnen JH, van Tellingen O (2007) P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin Cancer Res 13:6440\u20136449. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1335","journal-title":"Clin Cancer Res"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10637-010-9569-1","volume":"30","author":"NA Vries De","year":"2012","unstructured":"De Vries NA, Buckle T, Zhao J, Beijnen JH, Schellens JH, van Tellingen O (2012) Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-GP and BCRP. Invest New Drugs 30:443\u2013449","journal-title":"Invest New Drugs"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E et al (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907\u2013913","journal-title":"Nat Med"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K et al (2004) LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43:333\u2013344","journal-title":"Neuron"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Sagare A, Zlokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 8:16\u201330","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B et al (2012) A multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122:1377\u20131392","journal-title":"J Clin Invest"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","volume":"55","author":"AK Deo","year":"2014","unstructured":"Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B et al (2014) Activity of P-glycoprotein, a \u03b2-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer disease. J Nucl Med 55:1106\u20131111","journal-title":"J Nucl Med"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","volume":"82","author":"LY Marco Di","year":"2015","unstructured":"Di Marco LY, Venneri A, Farkas E, Evans PC, Marzo A, Frangi AF (2015) Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease \u2013 a review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis 82:593\u2013606","journal-title":"Neurobiol Dis"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JAD-2012-112189","volume":"30","author":"TM Do","year":"2012","unstructured":"Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S et al (2012) ABCG2- and ABCG4-mediated efflux of amyloid-\u03b2 peptide 1-40 at the mouse blood-brain barrier. J Alzheimers Dis 30:155\u2013166","journal-title":"J Alzheimers Dis"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.02.010","volume":"81","author":"TM Do","year":"2014","unstructured":"Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L et al (2014) Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer\u2019s disease. Neuropharmacology 81:311\u2013317","journal-title":"Neuropharmacology"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-150350","volume":"49","author":"TM Do","year":"2016","unstructured":"Do TM, Dodacki A, Alata W, Calon F, Nicolic S, Scherrmann JM et al (2016) Age-dependent regulation of the blood-brain barrier influx\/efflux equilibrium of amyloid-\u03b2 peptide in a mouse model of Alzheimer\u2019s disease (3xTg-AD). J Alzheimers Dis 49:287\u2013300","journal-title":"J Alzheimers Dis"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","volume":"42","author":"SM Dombrowski","year":"2001","unstructured":"Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W et al (2001) Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42:1501\u20131506","journal-title":"Epilepsia"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"J Donahue","year":"2006","unstructured":"Donahue J, Flaherty S, Johanson C, Duncan J, Silverberg G, Miller M et al (2006) RAGE, LRP-1, and amyloid-\u03b2 protein in Alzheimer\u2019s disease. Acta Neuropathol 112:405\u2013415","journal-title":"Acta Neuropathol"},{"key":"9_CR97","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/dmd.104.001230","volume":"33","author":"A Doran","year":"2005","unstructured":"Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E et al (2005) The impact of P-glycoproteinon the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model. Drug Metab Dispo 33:165\u2013174","journal-title":"Drug Metab Dispo"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00008571-200305000-00004","volume":"13","author":"M Dro\u017adzik","year":"2003","unstructured":"Dro\u017adzik M, Bia\u0142ecka M, My\u015bliwiec K, Honczarenko K, Stankiewicz J, Sych Z (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson\u2019s disease. Pharmacogenetics 13:259\u2013263","journal-title":"Pharmacogenetics"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4","volume":"61","author":"JE Duda","year":"2000","unstructured":"Duda JE, Lee VMY, Trojanowski JQ (2000) Neuropathy of synuclein aggregates: new insights into mechanisms of neurodegenerative diseases. J Neurosci Res 61:121\u2013127","journal-title":"J Neurosci Res"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","volume":"34","author":"MR Durk","year":"2014","unstructured":"Durk MR, Han K, Chow EC, Ahrens R, Henderson JT, Fraser PE et al (2014) 1\u03b1,25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease. J Neurosci 34:7091\u20137101","journal-title":"J Neurosci"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2013.06.009","volume":"76","author":"S Durmus","year":"2013","unstructured":"Durmus S, Xu N, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH (2013) P-glycoprotein (MDR1\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2) restrict brain accumulation of the JAK1\/2 inhibitor, CYT387. Pharmacol Res 76:9\u201316","journal-title":"Pharmacol Res"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11095-014-1442-z","volume":"32","author":"S Durmus","year":"2015","unstructured":"Durmus S, Sparidans RW, van Esch A, Wagenaar E, Beijnen JH, Schinkel AH (2015) Breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-GP\/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699). Pharm Res 32:37\u201346","journal-title":"Pharm Res"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archneurol.2010.101","volume":"67","author":"F Dutheil","year":"2010","unstructured":"Dutheil F, Beaune P, Tzourio C, Loriot MA, Elbaz A (2010) Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease. Arch Neurol 67:739\u2013745","journal-title":"Arch Neurol"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0006-8993(03)02401-6","volume":"971","author":"T Eisenblatter","year":"2003","unstructured":"Eisenblatter T, Huwel S, Galla HJ (2003) Characterisation of the brain multidrug resistance protein (BMDP\/ABCG2\/BCRP) expressed at the blood-brain barrier. Brain Res 971:221\u2013231","journal-title":"Brain Res"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33:1500\u20131513","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"9_CR1001","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.3390\/pharmaceutics10030102","volume":"10","author":"Y Fan","year":"2018","unstructured":"Fan Y, Liu X (2018) Alterations in expression and function of ABC family transporters at blood-brain barrier under liver failure and their clinical significances. Pharmaceutics 10(3):E102. https:\/\/doi.org\/10.3390\/pharmaceutics10030102","journal-title":"Pharmaceutics"},{"key":"9_CR106","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux BA, Bonnet AM, Agid Y, Hirsch EC (1999) Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease. Lancet 353:981\u2013982","journal-title":"Lancet"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1172\/JCI0215451","volume":"110","author":"S Fellner","year":"2002","unstructured":"Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T et al (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 110:1309\u20131318","journal-title":"J Clin Invest"},{"key":"9_CR108","first-page":"830","volume":"25","author":"D Fortin","year":"2004","unstructured":"Fortin D, Salam\u00e9 JA, Desjardins A, Benko A (2004) Technical modification in the intracarotid chemotherapy and osmotic blood-brain barrier disruption procedure to prevent the relapse of carboplatin-induced orbital pseudotumor. AJNR Am J Neuroradiol 25:830\u2013834","journal-title":"AJNR Am J Neuroradiol"},{"key":"9_CR109","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/cncr.21112","volume":"103","author":"D Fortin","year":"2005","unstructured":"Fortin D, Desjardins A, Benko A, Niyonsega T, Boudrias M (2005) Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. Cancer 103:2606\u20132615","journal-title":"Cancer"},{"key":"9_CR110","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1038\/sj.emboj.7600397","volume":"23","author":"L Fredriksson","year":"2004","unstructured":"Fredriksson L, Li H, Fieber C, Li X, Eriksson U (2004) Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 23:3793\u20133802","journal-title":"EMBO J"},{"key":"9_CR111","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1528-1167.2012.03666.x","volume":"53","author":"F Frigerio","year":"2012","unstructured":"Frigerio F, Frasca A, Weissberg I, Parrella S, Friedman A, Vezzani A et al (2012) Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia 53:1887\u20131897","journal-title":"Epilepsia"},{"key":"9_CR112","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000119383.76447.05","volume":"35","author":"S Fukuda","year":"2004","unstructured":"Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35:998\u20131004","journal-title":"Stroke"},{"key":"9_CR113","doi-asserted-by":"publisher","first-page":"48508","DOI":"10.1074\/jbc.M209085200","volume":"277","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW (2002) Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. J Biol Chem 277:48508\u201348513","journal-title":"J Biol Chem"},{"key":"9_CR114","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00702-009-0196-y","volume":"116","author":"C Funke","year":"2009","unstructured":"Funke C, Soehn AS, Tomiuk J, Riess O, Berg D (2009) Genetic analysis of coding SNPs in blood\u2013brain barrier transporter MDR1 in European Parkinson\u2019s diseasepatients. J Neural Transm 116:443\u2013450","journal-title":"J Neural Transm"},{"key":"9_CR115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00008571-200210000-00004","volume":"12","author":"T Furuno","year":"2002","unstructured":"Furuno T, Landi MT, Ceroni M, Caporaso N, Bernucci I, Nappi G et al (2002) Expression polymorphism of the blood\u2013brain barrier component P-glycoprotein (MDR1) in relation to Parkinson\u2019s disease. Pharmacogenetics 12:529\u2013534","journal-title":"Pharmacogenetics"},{"key":"9_CR116","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncel.2014.00021","volume":"8","author":"S Garbuzova-Davis","year":"2014","unstructured":"Garbuzova-Davis S, Sanberg PR (2014) Blood\u2013CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci 8:21","journal-title":"Front Cell Neurosci"},{"key":"9_CR117","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","volume":"1157","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR (2007a) Ultrastructure of blood\u2013brain barrier and blood\u2013spinal cord barrier in SOD1 mice modeling ALS. Brain Res 1157:126\u2013137","journal-title":"Brain Res"},{"key":"9_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001205","volume":"2","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H et al (2007b) Evidence of compromised blood\u2013spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2:e1205","journal-title":"PLoS One"},{"key":"9_CR119","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","volume":"1398","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis S, Rodrigues MCO, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV et al (2011) Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 1398:113\u2013125","journal-title":"Brain Res"},{"key":"9_CR120","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/pedi.12359","volume":"18","author":"A Garro","year":"2017","unstructured":"Garro A, Chodobski A, Szmydynger-Chodobska J, Shan R, Bialo SR, Bennett J et al (2017) Circulating matrix metalloproteinases in children with diabetic ketoacidosis. Pediatr Diabetes 18:95\u2013102","journal-title":"Pediatr Diabetes"},{"key":"9_CR121","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1523\/JNEUROSCI.0570-06.2006","volume":"26","author":"PJ Gasser","year":"2006","unstructured":"Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758\u20138766","journal-title":"J Neurosci"},{"key":"9_CR122","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/cne.21921","volume":"512","author":"PJ Gasser","year":"2009","unstructured":"Gasser PJ, Orchinik M, Raju I, Lowry CA (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512:529\u2013555","journal-title":"J Comp Neurol"},{"key":"9_CR123","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","volume":"54","author":"J Ghiso","year":"2002","unstructured":"Ghiso J, Frangione B (2002) Amyloidosis and Alzheimer\u2019s disease. Adv Drug Deliv Rev 54:1539\u20131551","journal-title":"Adv Drug Deliv Rev"},{"key":"9_CR124","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","volume":"88","author":"P Giannoni","year":"2016","unstructured":"Giannoni P, Arango-Lievano M, Neves ID, Rousset MC, Baranger K, Rivera S et al (2016) Cerebrovascular pathology during the progression of experimental Alzheimer\u2019s disease. Neurobiol Dis 88:107\u2013117","journal-title":"Neurobiol Dis"},{"key":"9_CR125","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.bjp.0705227","volume":"139","author":"KB Goralski","year":"2003","unstructured":"Goralski KB, Hartmann G, Piquette-Miller M, Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35\u201348","journal-title":"Br J Pharmacol"},{"key":"9_CR126","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.0000143224.36527.44","volume":"35","author":"SM Greenberg","year":"2004","unstructured":"Greenberg SM, Gurol ME, Rosand J, Smith EE (2004) Amyloid angiopathy-related vascular cognitive impairment. Stroke 35:2616\u20132619","journal-title":"Stroke"},{"key":"9_CR127","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1227\/01.NEU.0000365802.02410.C5","volume":"66","author":"DJ Guillaume","year":"2010","unstructured":"Guillaume DJ, Doolittle ND, Gahramanov S, Hedrick NA, Delashaw JB, Neuwelt EA (2010) Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery 66:48\u201358","journal-title":"Neurosurgery"},{"key":"9_CR128","first-page":"174","volume":"18","author":"A Gupta","year":"1999","unstructured":"Gupta A, Agarwal R, Shukla GS (1999) Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum Exp Toxicol 18:174\u2013179","journal-title":"Hum Exp Toxicol"},{"key":"9_CR129","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","volume":"29","author":"AM Haidet-Phillips","year":"2011","unstructured":"Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29:824\u2013828","journal-title":"Nat Biotechnol"},{"key":"9_CR130","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-005-9038-4","volume":"77","author":"WA Hall","year":"2006","unstructured":"Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al (2006) Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol 77:279\u2013884","journal-title":"J Neurooncol"},{"key":"9_CR131","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1124\/mol.105.017954","volume":"69","author":"AM Hartz","year":"2006","unstructured":"Hartz AM, Bauer B, Fricker G, Miller DS (2006) Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol 69:462\u2013470","journal-title":"Mol Pharmacol"},{"key":"9_CR132","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1124\/mol.109.061754","volume":"77","author":"AM Hartz","year":"2010","unstructured":"Hartz AM, Miller DS, Bauer B (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-\u03b2 in a mouse model of Alzheimer\u2019s disease. Mol Pharmacol 77:715\u2013723","journal-title":"Mol Pharmacol"},{"key":"9_CR133","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","volume":"50","author":"BT Hawkins","year":"2007","unstructured":"Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD (2007a) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50:202\u2013211","journal-title":"Diabetologia"},{"key":"9_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2006.09.010","volume":"411","author":"BT Hawkins","year":"2007","unstructured":"Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD (2007b) Decreased blood\u2013brain barrier permeability to fluorescein in streptozotocin-treated rats. Neurosci Lett 411:1\u20135","journal-title":"Neurosci Lett"},{"key":"9_CR135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.regpep.2004.05.023","volume":"123","author":"K Hayashi","year":"2004","unstructured":"Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, Niwa M (2004) Effects of hypoxia on endothelial\/pericytic co-culture model of the blood-brain barrier. Regul Pept 123:77\u201383","journal-title":"Regul Pept"},{"key":"9_CR136","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/156720206776875902","volume":"3","author":"T Hayashi","year":"2006","unstructured":"Hayashi T, Deguchi K, Nagotani S, Zhang H, Sehara Y, Tsuchiya A et al (2006) Cerebral ischemia and angiogenesis. Curr Neurovasc Res 3:119\u2013129","journal-title":"Curr Neurovasc Res"},{"key":"9_CR137","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel JS, Engelhardt JI, Sikl\u00f3s L, Simpson EP, Kim SH, Pan T et al (2004) Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221\u2013235","journal-title":"Ann Neurol"},{"key":"9_CR138","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","volume":"72","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Beers DR, Wen S, Bowser R, Appel SH (2009) Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72:1614\u20131616","journal-title":"Neurology"},{"key":"9_CR139","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11481-014-9557-x","volume":"9","author":"J Hill","year":"2014","unstructured":"Hill J, Rom S, Ramirez SH, Persidsky Y (2014) Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease. J Neuroimmune Pharmacol 9:591\u2013605","journal-title":"J Neuroimmune Pharmacol"},{"key":"9_CR140","doi-asserted-by":"publisher","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY et al (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279:41197\u201341207","journal-title":"J Biol Chem"},{"key":"9_CR141","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0304-3940(02)00816-9","volume":"334","author":"WH Hoffman","year":"2002","unstructured":"Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D (2002) Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett 334:71\u201374","journal-title":"Neurosci Lett"},{"key":"9_CR142","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2008.11.100","volume":"254","author":"WH Hoffman","year":"2009","unstructured":"Hoffman WH, Stamatovic SM, Jelkovic AV (2009) Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res 254:138\u2013148","journal-title":"Brain Res"},{"key":"9_CR143","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1528-1167.2006.00939.x","volume":"48","author":"K Hoffmann","year":"2007","unstructured":"Hoffmann K, L\u00f6scher W (2007) Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR\u2212Rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Epilepsia 48:631\u2013645","journal-title":"Epilepsia"},{"key":"9_CR144","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2174\/15672050113106660171","volume":"10","author":"J Hofrichter","year":"2013","unstructured":"Hofrichter J, Krohn M, Schumacher T, Lange C, Feistel B, Walbroel B et al (2013) Reduced Alzheimer\u2019s disease pathology by St. John\u2019s Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice. Curr Alzheimer Res 10:1057\u20131069","journal-title":"Curr Alzheimer Res"},{"key":"9_CR145","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D et al (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726","journal-title":"Brain"},{"key":"9_CR146","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s11064-015-1814-8","volume":"41","author":"Y Hong","year":"2016","unstructured":"Hong Y, Shen C, Yin Q, Sun M, Ma Y, Liu X (2016) Effects of RAGE-specific inhibitor FPS-ZM1 on amyloid-\u03b2 metabolism and AGEs-induced inflammation and oxidative stress in rat hippocampus. Neurochem Res 41:1192\u20131199","journal-title":"Neurochem Res"},{"key":"9_CR147","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2007.08.063","volume":"1181","author":"CR Hooijmans","year":"2007","unstructured":"Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP\/PS1 mice. Brain Res 1181:93\u2013103","journal-title":"Brain Res"},{"key":"9_CR148","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","volume":"103","author":"Y Hu","year":"2007","unstructured":"Hu Y, Shen H, Keep RF, Smith DE (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem 103:2058\u20132065","journal-title":"J Neurochem"},{"key":"9_CR149","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00432-007-0323-9","volume":"134","author":"M Hubensack","year":"2008","unstructured":"Hubensack M, Muller C, Hocherl P, Fellner S, Spruss T, Bernhardt G et al (2008) Effect of the ABCB1modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice. J Cancer Res Clin Oncol 134:597\u2013607","journal-title":"J Cancer Res Clin Oncol"},{"key":"9_CR150","doi-asserted-by":"publisher","first-page":"C795","DOI":"10.1152\/ajpcell.00597.2005","volume":"292","author":"RD Huber","year":"2007","unstructured":"Huber RD, Gao B, Sidler Pfandler MA, Zhang-Fu W, Leuthold S, Hagenbuch B et al (2007) Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am J Physiol Cell Physiol 292:C795\u2013C806","journal-title":"Am J Physiol Cell Physiol"},{"key":"9_CR151","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/bdd.371","volume":"24","author":"A Inano","year":"2003","unstructured":"Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A et al (2003) Acetyl-Lcarnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24:357\u2013365","journal-title":"Biopharm Drug Dispos"},{"key":"9_CR152","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1056-8727(99)00030-6","volume":"13","author":"CM Isales","year":"1999","unstructured":"Isales CM, Min L, Hoffman WH (1999) Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diab Comp 13:91\u201397","journal-title":"J Diab Comp"},{"key":"9_CR153","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1600-0404.2007.00876.x","volume":"116","author":"T Ishikawa","year":"2007","unstructured":"Ishikawa T, Morita M, Nakano I (2007) Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia \u2013 a SPECT study with 3D-SSP. Acta Neurol Scand 116:340\u2013344","journal-title":"Acta Neurol Scand"},{"key":"9_CR154","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","volume":"47","author":"MR Jablonski","year":"2012","unstructured":"Jablonski MR, Jacob MA, Campos C, Miller DS, Maragakis NJ, Piera Pasinelli P et al (2012) Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. Neurobiol Dis 47:194\u2013200","journal-title":"Neurobiol Dis"},{"key":"9_CR155","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/acn3.141","volume":"1","author":"MR Jablonski","year":"2014","unstructured":"Jablonski MR, Markandaiah SS, Jacob D, Meng NJ, Li K, Gennaro V et al (2014) Inhibiting drug efflux transporters improves efficacy of ALS therapeutics. Ann Clin Transl Neurol 1:996\u20131005","journal-title":"Ann Clin Transl Neurol"},{"key":"9_CR156","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-2009-1074","volume":"17","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA et al (2009) Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 17:553\u2013570","journal-title":"J Alzheimers Dis"},{"key":"9_CR157","doi-asserted-by":"publisher","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","volume":"32","author":"WJ Jagust","year":"2012","unstructured":"Jagust WJ, Landau SM, Alzheimer\u2019s Disease Neuroimaging Initiative (2012) Apolipoprotein E, not fibrillar beta amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci 32:18227\u201318233","journal-title":"J Neurosci"},{"key":"9_CR158","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegen Dis 7:112\u2013115","journal-title":"Neurodegen Dis"},{"key":"9_CR159","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neulet.2010.10.063","volume":"487","author":"B Jeynes","year":"2011","unstructured":"Jeynes B, Provias J (2011) An investigation into the role of P-glycoprotein in Alzheimer\u2019s disease lesion pathogenesis. Neurosci Lett 487:389\u2013393","journal-title":"Neurosci Lett"},{"key":"9_CR160","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/j.1471-4159.2009.06090.x","volume":"109","author":"H Jiang","year":"2009","unstructured":"Jiang H, Hu Y, Keep RF, Smith DE (2009) Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice. J Neurochem 109:1536\u20131543","journal-title":"J Neurochem"},{"key":"9_CR161","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/j.1476-5381.2009.00634.x","volume":"159","author":"X Jing","year":"2010","unstructured":"Jing X, Liu X, Wen T, Xie S, Yao D, Liu X et al (2010) Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats. Brit J Pharmacol 159:1511\u20131522","journal-title":"Brit J Pharmacol"},{"key":"9_CR162","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.bjp.0702497","volume":"127","author":"JW Jonker","year":"1999","unstructured":"Jonker JW, Wagenaar E, van Deemter L, Gottschlich R, Bender HM, Dasenbrock J et al (1999) Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, aperipherally acting analgaesic drug. Brit J Pharmacol 127:43\u201350","journal-title":"Brit J Pharmacol"},{"key":"9_CR163","first-page":"17","volume":"19","author":"KM Joo","year":"2008","unstructured":"Joo KM, Park K, Kong DS, Song SY, Kim MH, Lee GS et al (2008) Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor. Oncol Rep 19:17\u201323","journal-title":"Oncol Rep"},{"key":"9_CR164","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.12659\/MSM.893375","volume":"21","author":"C Ju","year":"2015","unstructured":"Ju C, Ye M, Li F (2015) Plasma brain natriuretic peptide, endothelin-1, and matrix metalloproteinase 9 expression and significance in type 2 diabetes mellitus patients with ischemic heart disease. Med Sci Monit 21:2094\u20132099","journal-title":"Med Sci Monit"},{"key":"9_CR165","doi-asserted-by":"publisher","first-page":"R986","DOI":"10.1152\/ajpregu.90744.2008","volume":"296","author":"MA Kamal","year":"2009","unstructured":"Kamal MA, Jiang H, Hu Y, Keep RF, Smith DE (2009) Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. Am J Physiol Regul Integr Comp Physiol 296:R986\u2013R991","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9_CR166","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1254\/jphs.FP0040832","volume":"97","author":"J Kamei","year":"2005","unstructured":"Kamei J, Hirano S, Miyata S, Saito A, Onodera K (2005) Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice. J Pharmacol Sci 97:266\u2013272","journal-title":"J Pharmacol Sci"},{"key":"9_CR167","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.1243619","volume":"341","author":"F Kamel","year":"2013","unstructured":"Kamel F (2013) Epidemiology. Paths from pesticides to Parkinson\u2019s. Science 341:722\u2013723","journal-title":"Science"},{"key":"9_CR168","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","volume":"25","author":"J Kamiie","year":"2008","unstructured":"Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K et al (2008) Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria. Pharm Res 25:1469\u20131483","journal-title":"Pharm Res"},{"key":"9_CR169","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JPD-012138","volume":"2","author":"NM Kanaan","year":"2012","unstructured":"Kanaan NM, Manfredsson FP (2012) Loss of functional alpha-synuclein: A toxic event in Parkinson\u2019s disease? J Parkinsons Dis 2:249\u2013267","journal-title":"J Parkinsons Dis"},{"key":"9_CR170","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1016\/j.xphs.2017.04.040","volume":"106","author":"K Kanamitsu","year":"2017","unstructured":"Kanamitsu K, Kusuhara H, Schuetz JD, Takeuchi K, Sugiyama Y (2017) Investigation of the importance of multidrug resistance-associated protein 4 (Mrp4\/Abcc4) in the active efflux of anionic drugs across the blood-brain barrier. J Pharm Sci 106:2566\u20132575","journal-title":"J Pharm Sci"},{"key":"9_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.08.044","volume":"1418","author":"KD Kania","year":"2011","unstructured":"Kania KD, Wijesuriya HC, Hladky SB, Barrand MA (2011) Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells. Brain Res 1418:1\u201311","journal-title":"Brain Res"},{"key":"9_CR172","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1016\/j.lfs.2003.06.014","volume":"73","author":"M Kaya","year":"2003","unstructured":"Kaya M, Kalayci R, K\u00fcc\u00fck M, Arican N, Elmas I, Kudat H et al (2003) Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats. Life Sci 73:3235\u20133244","journal-title":"Life Sci"},{"key":"9_CR173","first-page":"2849","volume":"9","author":"EM Kemper","year":"2003","unstructured":"Kemper EM, van Zandbergen AE, Cleypool C, Mos HA, Boogerd W, Beijnen JH et al (2003) Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein. Clin Cancer Res 9:2849\u20132855","journal-title":"Clin Cancer Res"},{"key":"9_CR174","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00280-003-0720-y","volume":"53","author":"EM Kemper","year":"2004","unstructured":"Kemper EM, Cleypool C, Boogerd W, Beijnen JH, van Tellingen O (2004a) The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice. Cancer Chemother Pharmacol 53:173\u2013178","journal-title":"Cancer Chemother Pharmacol"},{"key":"9_CR175","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ejca.2004.01.024","volume":"40","author":"EM Kemper","year":"2004","unstructured":"Kemper EM, Verheij M, Boogerd W, Beijnen JH, van Tellingen O (2004b) Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer 40:1269\u20131274","journal-title":"Eur J Cancer"},{"key":"9_CR176","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/j.1471-4159.2005.03309.x","volume":"94","author":"ST Khuth","year":"2005","unstructured":"Khuth ST, Strazielle N, Giraudon P, Belin MF, Ghersi-Egea JF (2005) Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem 94:1580\u20131593","journal-title":"J Neurochem"},{"key":"9_CR177","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1471-4159.2001.00621.x","volume":"79","author":"Y Kido","year":"2001","unstructured":"Kido Y, Tamai I, Ohnari A, Sai Y, Kagami T, Nezu J et al (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-Lcarnitine across the blood brain barrier. J Neurochem 79:959\u2013969","journal-title":"J Neurochem"},{"key":"9_CR178","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0306-4522(02)00993-4","volume":"19","author":"HC Kim","year":"2003","unstructured":"Kim HC, Yamada K, Nitta A, Olariu A, Tran MH, Mizuno M et al (2003) Immunocytochemical evidence that amyloid beta (1\u201342) impairs endogenous antioxidant systems in vivo. Neuroscience 19:399\u2013419","journal-title":"Neuroscience"},{"key":"9_CR179","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1093\/brain\/awv327","volume":"138","author":"IF Kimbrough","year":"2015","unstructured":"Kimbrough IF, Robel S, Roberson ED, Sontheimer H (2015) Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer\u2019s disease. Brain 138:3716\u20133733","journal-title":"Brain"},{"key":"9_CR180","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1152\/japplphysiol.01259.2005","volume":"100","author":"B Kis","year":"2006","unstructured":"Kis B, Isse T, Snipes JA, Chen L, Yamashita H, Ueta Y et al (2006) Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood brain and blood-cerebrospinal fluid barriers. J Appl Physiol 100:1392\u20131399","journal-title":"J Appl Physiol"},{"key":"9_CR181","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00001756-200604240-00020","volume":"17","author":"PM Klinge","year":"2006","unstructured":"Klinge PM, Samii A, Niescken S, Brinker T, Silverberg GD (2006) Brain amyloid accumulates in aged rats with kaolin-induced hydrocephalus. Neuroreport 17:657\u2013660","journal-title":"Neuroreport"},{"key":"9_CR182","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1124\/jpet.109.162321","volume":"333","author":"H Kodaira","year":"2010","unstructured":"Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y (2010) Kinetic analysis of the cooperation of P-glycoprotein (P-GP\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J Pharmacol Exp Ther 333:788\u2013796","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR183","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I (2005) Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280:43224\u201343235","journal-title":"J Biol Chem"},{"key":"9_CR184","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.phrs.2015.09.003","volume":"102","author":"A Kort","year":"2015","unstructured":"Kort A, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH (2015a) Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2). Pharmacol Res 102:200\u2013207","journal-title":"Pharmacol Res"},{"key":"9_CR185","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s11095-014-1609-7","volume":"32","author":"A Kort","year":"2015","unstructured":"Kort A, Durmus S, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH (2015b) Brain and testis accumulation of regorafenib is restricted by breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-GP\/ABCB1). Pharm Res 32:2205\u20132216","journal-title":"Pharm Res"},{"key":"9_CR186","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT et al (2005) Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol 57:176\u2013179","journal-title":"Ann Neurol"},{"key":"9_CR187","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ana.10500","volume":"53","author":"J Kriz","year":"2003","unstructured":"Kriz J, Gowing G, Julien JP (2003) Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 53:429\u2013436","journal-title":"Ann Neurol"},{"key":"9_CR188","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1172\/JCI57867","volume":"121","author":"M Krohn","year":"2011","unstructured":"Krohn M, Lange C, Hofrichter J, Scheffler K, Stenzel J, Steffen J et al (2011) Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest 121:3924\u20133931","journal-title":"J Clin Invest"},{"key":"9_CR189","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.eplepsyres.2005.11.011","volume":"68","author":"H Kubota","year":"2006","unstructured":"Kubota H, Ishihara H, Langmann T, Schmitz G, Stieger B, Wieser HG et al (2006) Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res 68:213\u2013228","journal-title":"Epilepsy Res"},{"key":"9_CR190","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1124\/jpet.115.226373","volume":"355","author":"SE Lacher","year":"2015","unstructured":"Lacher SE, Skagen K, Veit J, Dalton R, Woodahl EL (2015) P-glycoprotein transport of neurotoxic pesticides. J Pharmacol Exp Ther 355:99\u2013107","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR191","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","volume":"76","author":"FC Lam","year":"2001","unstructured":"Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ et al (2001) Beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121\u20131128","journal-title":"J Neurochem"},{"key":"9_CR192","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL et al (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32:1207\u20131278","journal-title":"Neurobiol Aging"},{"key":"9_CR193","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","volume":"585","author":"C Larochelle","year":"2011","unstructured":"Larochelle C, Alvarez JI, Prat A (2011) How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585:3770\u20133780","journal-title":"FEBS Lett"},{"key":"9_CR194","first-page":"472","volume":"1862","author":"MA L\u00e9cuyer","year":"2016","unstructured":"L\u00e9cuyer MA, Kebir H, Prat A (2016) Glial influences on BBB functions and molecular players in immune cell trafficking. Bioch Biophy Acta 1862:472\u2013482","journal-title":"Bioch Biophy Acta"},{"key":"9_CR195","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.1074\/jbc.M107348200","volume":"277","author":"TH Lee","year":"2002","unstructured":"Lee TH, Avraham H, Lee SH, Avraham S (2002) Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem 277:10445\u201310451","journal-title":"J Biol Chem"},{"key":"9_CR196","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.013003","volume":"41","author":"CG Lee","year":"2004","unstructured":"Lee CG, Tang K, Cheung YB, Wong LP, Tan C, Shen H et al (2004) MDR1, the blood\u2013brain barrier transporter, is associated with Parkinson\u2019s disease in ethnic Chinese. J Med Genet 41:e60","journal-title":"J Med Genet"},{"key":"9_CR197","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1124\/jpet.104.073320","volume":"312","author":"YJ Lee","year":"2005","unstructured":"Lee YJ, Kusuhara H, Jonker JW, Schinkel AH, Sugiyama Y (2005a) Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J Pharmacol Exp Ther 312:44\u201352","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR198","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1074\/jbc.M411092200","volume":"280","author":"W Lee","year":"2005","unstructured":"Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G et al (2005b) Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol chem 280:9610\u20139617","journal-title":"J Biol chem"},{"key":"9_CR1002","doi-asserted-by":"publisher","DOI":"10.1042\/AN20090015","volume":"1","author":"I Lefterov","year":"2009","unstructured":"Lefterov I, Fitz NF, Cronican A, Lefterov P, Staufenbiel M, Koldamova R (2009) Memory deficits in APP23\/Abca1+\/\u2212 mice correlate with the level of A\u03b2 oligomers. ASN Neuro 1. pii:e00006. https:\/\/doi.org\/10.1042\/AN20090015","journal-title":"ASN Neuro"},{"key":"9_CR199","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","volume":"24","author":"M Leggas","year":"2004","unstructured":"Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G et al (2004) Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 24:7612\u20137621","journal-title":"Mol Cell Biol"},{"key":"9_CR1003","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jnnp-2013-305858","volume":"85","author":"M Lehmann","year":"2014","unstructured":"Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O\u2019Neil JP et al (2014) Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. J Neurol Neurosurg Psychiatry 85:266\u2013273. https:\/\/doi.org\/10.1136\/jnnp-2013-305858","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9_CR200","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","volume":"277","author":"QF Lenz","year":"2014","unstructured":"Lenz QF, Arroyo DS, Temp FR, Poersch AB, Masson CJ, Jesse AC et al (2014) Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction. Neuroscience 277:859\u2013871","journal-title":"Neuroscience"},{"key":"9_CR201","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-015-1520-2","volume":"131","author":"SA Lewandowski","year":"2016","unstructured":"Lewandowski SA, Nilsson I, Fredriksson L, L\u00f6nnerberg P, Muhl L, Zeitelhofer M et al (2016) Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration. Acta Neuropathol 131:453\u2013464","journal-title":"Acta Neuropathol"},{"key":"9_CR202","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1124\/dmd.112.049254","volume":"41","author":"L Li","year":"2013","unstructured":"Li L, Agarwal S, Elmquist WF (2013a) Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate. Drug Metab Dispos 41:659\u2013667","journal-title":"Drug Metab Dispos"},{"key":"9_CR203","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-2094-10-80","volume":"10","author":"YJ Li","year":"2013","unstructured":"Li YJ, Wang ZH, Zhang B, Zhe X, Wang MJ, Shi ST et al (2013b) Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflammation 10:80","journal-title":"J Neuroinflammation"},{"key":"9_CR204","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neulet.2014.02.025","volume":"566","author":"Y Li","year":"2014","unstructured":"Li Y, Li Y, Pang S, Huang W, Zhang A, Hawley RG et al (2014) Novel and functional ABCB1 gene variant in sporadic Parkinson\u2019s disease. Neurosci Lett 566:61\u201366","journal-title":"Neurosci Lett"},{"key":"9_CR205","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao B, Zhao W, Beers DR, Henkel JS, Appel SH (2012) Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 237:147\u2013152","journal-title":"Exp Neurol"},{"key":"9_CR206","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.23567","volume":"72","author":"L Librizzi","year":"2012","unstructured":"Librizzi L, No\u00e8 F, Vezzani A, de Curtis M, Ravizza T (2012) Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 72:82\u201390","journal-title":"Ann Neurol"},{"key":"9_CR207","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","volume":"114","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Tai Y, Huang MT, Tsai YF, Hsu HJ, Tzen KY et al (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 114:717\u2013727","journal-title":"J Neurochem"},{"key":"9_CR208","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fphar.2014.00273","volume":"5","author":"L Liu","year":"2014","unstructured":"Liu L, Liu XD (2014) Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances. Front Pharmacol 5:273","journal-title":"Front Pharmacol"},{"key":"9_CR209","first-page":"225","volume":"23","author":"XD Liu","year":"2002","unstructured":"Liu XD, Pan GY, Xie L, Hou YY, Lan W, Su Q et al (2002) Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats. Acta Pharmacol Sin 23:225\u2013229","journal-title":"Acta Pharmacol Sin"},{"key":"9_CR210","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF03220184","volume":"28","author":"XD Liu","year":"2003","unstructured":"Liu XD, Zhang L, Xie L (2003) Effect of P-glycoprotein inhibitors erythromycin and cyclosporine A on brain pharmacokinetics of nimodipine in rats. Eur J Drug Metab Pharmacokinet 28:309\u2013313","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"9_CR211","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.brainres.2006.09.061","volume":"1123","author":"HY Liu","year":"2006","unstructured":"Liu HY, Xu X, Yang ZH, Deng YX, Liu XD (2006) Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res 1123:245\u2013252","journal-title":"Brain Res"},{"key":"9_CR212","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.neuropharm.2007.07.012","volume":"53","author":"XD Liu","year":"2007","unstructured":"Liu XD, Yang ZH, Yang JS, Yang HW (2007a) Increased P-glycoprotein expression and decreased Phenobarbital distribution in the brain of pentylenetetrazole-kindled rats. Neuropharmacology 53:657\u2013663","journal-title":"Neuropharmacology"},{"key":"9_CR213","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2007.01.062","volume":"561","author":"H Liu","year":"2007","unstructured":"Liu H, Zhang D, Xu X, Liu X, Wang G, Xie L et al (2007b) Attenuated function and expression of P-glycoprotein at blood\u2013brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice. Eur J Pharmacol 561:226\u2013232","journal-title":"Eur J Pharmacol"},{"key":"9_CR214","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.bcp.2007.08.021","volume":"74","author":"YC Liu","year":"2007","unstructured":"Liu YC, Liu HY, Yang HW, Wen T, Shang Y, Liu XD et al (2007c) Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats. Biochem Pharmacol 74:1766\u20131772","journal-title":"Biochem Pharmacol"},{"key":"9_CR215","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/jnr.21558","volume":"86","author":"LB Liu","year":"2008","unstructured":"Liu LB, Xue YX, Liu YH, Wang YB (2008a) Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res 86:1153\u20131168","journal-title":"J Neurosci Res"},{"key":"9_CR216","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2008.10.070","volume":"432","author":"XD Liu","year":"2008","unstructured":"Liu XD, Yang ZH, Yang HW (2008b) Repetitive\/temporal hypoxia increased -glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro. Neurosci Lett 432:184\u2013187","journal-title":"Neurosci Lett"},{"key":"9_CR217","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuroscience.2008.03.019","volume":"153","author":"Y Liu","year":"2008","unstructured":"Liu Y, Liu H, Yang J, Liu X, Lu S, Wen T et al (2008c) Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats. Neurosicence 153:796\u2013802","journal-title":"Neurosicence"},{"key":"9_CR218","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.bcp.2008.01.004","volume":"75","author":"H Liu","year":"2008","unstructured":"Liu H, Liu X, Jia L, Liu Y, Yang H, Wang G et al (2008d) Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes. Biochem Pharmacol 75:1649\u20131658","journal-title":"Biochem Pharmacol"},{"key":"9_CR219","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejphar.2008.11.026","volume":"602","author":"HY Liu","year":"2009","unstructured":"Liu HY, Yang HW, Wang DL, Liu LC, Liu XD, Li Y et al (2009) Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC\/NF-B pathway but not a PI3K\/Akt pathway. Eur J Pharmacol 602:277\u2013282","journal-title":"Eur J Pharmacol"},{"key":"9_CR220","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1734-1140(11)70515-1","volume":"63","author":"X Liu","year":"2011","unstructured":"Liu X, Jing XY, Jin S, Li Y, Liu L, Yu YL et al (2011) Insulin suppresses the expression and function of breast cancer resistance protein in primary cultures of rat brain microvessel endothelial cells. Pharmacol Rep 63:487\u2013493","journal-title":"Pharmacol Rep"},{"key":"9_CR221","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuint.2014.05.004","volume":"75","author":"L Liu","year":"2014","unstructured":"Liu L, Wan W, Xia S, Kalionis B, Li Y (2014) Dysfunctional Wnt\/\u03b2-catenin signaling contributes to blood\u2013brain barrier breakdown in Alzheimer\u2019s disease. Neurochem Int 75:19\u201325","journal-title":"Neurochem Int"},{"key":"9_CR222","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J et al (2004) A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease. J Am Geriatr Soc 52:381\u2013387","journal-title":"J Am Geriatr Soc"},{"key":"9_CR223","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1124\/jpet.301.1.7","volume":"30","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 30:7\u201314","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR224","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","volume":"18","author":"MA Lovell","year":"1997","unstructured":"Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer\u2019s disease. Neurobiol Aging 18:457\u2013461","journal-title":"Neurobiol Aging"},{"key":"9_CR225","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM et al (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol 171:29\u201345","journal-title":"Exp Neurol"},{"key":"9_CR226","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","volume":"55","author":"C Luna-Tort\u00f3s","year":"2008","unstructured":"Luna-Tort\u00f3s C, Fedrowitz M, L\u00f6scher W (2008) Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 55:1364\u20131375","journal-title":"Neuropharmacology"},{"key":"9_CR227","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","volume":"9","author":"L Maia","year":"2002","unstructured":"Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer\u2019s disease? Eur J Neurol 9:377\u2013382","journal-title":"Eur J Neurol"},{"key":"9_CR228","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/j.1528-1167.2007.01185.x","volume":"48","author":"N Marchi","year":"2007","unstructured":"Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernande N et al (2007a) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48:1934\u20131946","journal-title":"Epilepsia"},{"key":"9_CR229","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","volume":"48","author":"N Marchi","year":"2007","unstructured":"Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N et al (2007b) Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48:732\u2013742","journal-title":"Epilepsia"},{"key":"9_CR230","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000100019","volume":"23","author":"Y Matsumoto","year":"2007","unstructured":"Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M (2007) Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 23:241\u2013245","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9_CR231","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2012.07.004","volume":"524","author":"J Matsumoto","year":"2012","unstructured":"Matsumoto J, Dohgu S, Takata F, Nishioku T, Sumi N, Machida T et al (2012) Lipopolysaccharide-activated microglia lower P-glycoprotein function in brain microvascular endothelial cells. Neurosci Lett 524:45\u201348","journal-title":"Neurosci Lett"},{"key":"9_CR232","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","volume":"5","author":"J Matsumoto","year":"2017","unstructured":"Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N (2017) Transmission of \u03b1-synuclein-containing erythrocyte-derived extracellular vesiclesacross the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson\u2019s disease? Acta Neuropathol Commun 5:71","journal-title":"Acta Neuropathol Commun"},{"key":"9_CR233","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1172\/JCI119784","volume":"100","author":"U Mayer","year":"1997","unstructured":"Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, Schinkel AH (1997) Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100:2430\u20132436","journal-title":"J Clin Invest"},{"key":"9_CR234","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1172\/JCI70324","volume":"124","author":"S Mayerl","year":"2014","unstructured":"Mayerl S, M\u00fcller J, Bauer R, Richert S, Kassmann CM, Darras VM et al (2014) Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest 124:1987\u20131999","journal-title":"J Clin Invest"},{"key":"9_CR235","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1111\/j.1471-4159.2008.05582.x","volume":"106","author":"G McCaffrey","year":"2008","unstructured":"McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR et al (2008) Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem 106:2395\u20132409","journal-title":"J Neurochem"},{"key":"9_CR236","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","volume":"94","author":"LT McGrath","year":"2001","unstructured":"McGrath LT, McGleenon BM, Brennan S, McColl D, Mc IS, Passmore AP (2001) Increased oxidative stress in Alzheimer\u2019s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 94:485\u2013490","journal-title":"QJM"},{"key":"9_CR237","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","volume":"111","author":"K Meyer","year":"2014","unstructured":"Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S et al (2014) Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA 111:829\u2013832","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR238","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","volume":"472","author":"A Milane","year":"2010","unstructured":"Milane A, Fernandez C, Dupuis L, Buyse M, Loeffler JP, Farinotti R et al (2010) P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis. Neurosci Lett 472:166\u2013170","journal-title":"Neurosci Lett"},{"key":"9_CR239","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","volume":"31","author":"DS Miller","year":"2010","unstructured":"Miller DS (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 31:246\u2013254","journal-title":"Trends Pharmacol Sci"},{"key":"9_CR240","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","volume":"1230","author":"MC Miller","year":"2008","unstructured":"Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L et al (2008) Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease. Brain Res 1230:273\u2013280","journal-title":"Brain Res"},{"key":"9_CR241","doi-asserted-by":"publisher","first-page":"16394","DOI":"10.1073\/pnas.0603734103","volume":"103","author":"P Mitra","year":"2006","unstructured":"Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103:16394\u201316399","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR242","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.112.192195","volume":"342","author":"RK Mittapalli","year":"2012","unstructured":"Mittapalli RK, Vaidhyanathan S, Sane R, Elmquist WF (2012) Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: Vemurafenib (PLX 4032). J Pharmacol Exp Ther 342:33\u201340","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR243","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jnr.22594","volume":"89","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y et al (2011) Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res 89:718\u2013728","journal-title":"J Neurosci Res"},{"key":"9_CR244","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/jcbfm.2011.155","volume":"32","author":"K Miyazaki","year":"2012","unstructured":"Miyazaki K, Masamoto K, Morimoto N, Kurata T, Mimoto T, Obata T et al (2012) Early and progressive impairment of spinal blood flow\u2013glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32:456\u2013446","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR245","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1253\/circj.CJ-11-0121","volume":"75","author":"M Mogi","year":"2011","unstructured":"Mogi M, Horiuchi M (2011) Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J 75:1042\u20131048","journal-title":"Circ J"},{"key":"9_CR247","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","volume":"28","author":"DW Molloy","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q, Guyatt G (2013) A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial. Int J Geriatr Psychiatry 28:463\u2013470","journal-title":"Int J Geriatr Psychiatry"},{"key":"9_CR248","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1124\/dmd.113.055566","volume":"42","author":"RN Montesinos","year":"2014","unstructured":"Montesinos RN, Moulari B, Gromand J, Beduneau A, Lamprecht A, Pellequer Y (2014) Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution. Drug Metab Dispos 42:700\u2013706","journal-title":"Drug Metab Dispos"},{"key":"9_CR249","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21:10609\u201310620","journal-title":"World J Gastroenterol"},{"key":"9_CR250","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0006-8993(03)03374-2","volume":"989","author":"T Murakami","year":"2003","unstructured":"Murakami T, Ilieva H, Shiote M, Nagata T, Nagano I, Shoji M, Abe K (2003) Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res 989:231\u2013237","journal-title":"Brain Res"},{"key":"9_CR251","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615\u2013622","journal-title":"Nat Neurosci"},{"key":"9_CR252","first-page":"142","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D (2013) Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation 10:142","journal-title":"J Neuroinflammation"},{"key":"9_CR253","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fpsyt.2017.00083","volume":"8","author":"S Najjar","year":"2017","unstructured":"Najjar S, Pahlajani S, De Sanctis V, Stern JNH, Najjar A, Chong D (2017) Neurovascular unit dysfunction and blood-brain barrier hyperpermeability contribute to schizophrenia neurobiology: A theoretical integration of clinical and experimental evidence. Front Psychiatry 8:83","journal-title":"Front Psychiatry"},{"key":"9_CR254","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10571-007-9195-4","volume":"27","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Deli MA, Nakao S, Honda M, Hayashi K, Nakaoke R et al (2007) Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 27:687\u2013694","journal-title":"Cell Mol Neurobiol"},{"key":"9_CR255","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood-2005-10-4020","volume":"108","author":"T Nakanishi","year":"2006","unstructured":"Nakanishi T, Shiozawa K, Hassel BA, Ross DD (2006) Complex interaction of BCRP\/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated byimatinib-induced reduction of BCRP expression. Blood 108:678\u2013684","journal-title":"Blood"},{"key":"9_CR256","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.envres.2015.08.022","volume":"143","author":"S Narayan","year":"2015","unstructured":"Narayan S, Sinsheimer JS, Paul KC, Liew Z, Cockburn M, Bronstein JM et al (2015) Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson\u2019s disease. Environ Res 143:98\u2013106","journal-title":"Environ Res"},{"key":"9_CR257","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","volume":"1301","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A et al (2009a) Impaired blood\u2013brain and blood\u2013spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 1301:152\u2013162","journal-title":"Brain Res"},{"key":"9_CR258","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ar.20838","volume":"292","author":"C Nicaise","year":"2009","unstructured":"Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, Delporte C et al (2009b) Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken) 292:207\u2013213","journal-title":"Anat Rec (Hoboken)"},{"key":"9_CR259","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","volume":"129","author":"AT Nies","year":"2004","unstructured":"Nies AT, Jedlitschky G, K\u00f6nig J, Herold-Mende C, Steiner HH, Schmitt HP et al (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129:349\u2013360","journal-title":"Neuroscience"},{"key":"9_CR260","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/epi.13394","volume":"57","author":"FM No\u00e9","year":"2016","unstructured":"No\u00e9 FM, Bellistri E, Colciaghi F, Cipelletti B, Battaglia G et al (2016) Kainic acid\u2013induced albumin leak across the blood\u2013brain barrier facilitates epileptiform hyperexcitability in limbic regions. Epilepsia 57:967\u2013976","journal-title":"Epilepsia"},{"key":"9_CR261","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/npp.2013.120","volume":"38","author":"FE O\u2019Brien","year":"2013","unstructured":"O\u2019Brien FE, O\u2019Connor RM, Clarke G, Dinan TG, Griffin BT, Cryan JF (2013) P-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodents. Neuropsychopharmacology 38:2209\u20132219","journal-title":"Neuropsychopharmacology"},{"key":"9_CR262","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2013.11.027","volume":"261","author":"FE O\u2019Brien","year":"2014","unstructured":"O\u2019Brien FE, O\u2019Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT et al (2014) The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram. Behav Brain Res 261:17\u201325","journal-title":"Behav Brain Res"},{"key":"9_CR263","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1124\/jpet.113.208959","volume":"347","author":"RK Oberoi","year":"2013","unstructured":"Oberoi RK, Mittapalli RK, Elmquist WF (2013) Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain. J Pharmacol Exp Ther 347:755\u2013764","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR264","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/dmd.108.024018","volume":"37","author":"A Ose","year":"2009","unstructured":"Ose A, Ito M, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M et al (2009) Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene- 1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3\/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4\/Abcc4). Drug Metab Dispos 37:315\u2013321","journal-title":"Drug Metab Dispos"},{"key":"9_CR265","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","volume":"49","author":"JB Owen","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G et al (2010) Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain. Free Radic Biol Med 49:1798\u20131803","journal-title":"Free Radic Biol Med"},{"key":"9_CR266","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0278-5846(03)00084-8","volume":"27","author":"B Ozta\u015f","year":"2003","unstructured":"Ozta\u015f B, Kaya M, K\u00fc\u00e7\u00fck M, Tu\u011fran N (2003) Influence of hypoosmolality on the blood-brain barrier permeability during epileptic seizures. Prog Neuropsychopharmacol Biol Psychiatry 27:701\u2013704","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9_CR267","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nbd.2014.04.001","volume":"72","author":"J Pahnke","year":"2014","unstructured":"Pahnke J, Langer O, Krohn M (2014) Alzheimer\u2019s and ABC transporters - new opportunities for diagnostics and treatment. Neurobiol Dis 72:54\u201360","journal-title":"Neurobiol Dis"},{"key":"9_CR268","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1161\/STROKEAHA.114.005179","volume":"45","author":"L Park","year":"2014","unstructured":"Park L, Koizumi K, El Jamal S, Zhou P, Previti ML, Van Nostrand WE et al (2014a) Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke 45:1815\u20131821","journal-title":"Stroke"},{"key":"9_CR269","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.258","volume":"5","author":"P Park","year":"2014","unstructured":"Park P, Kook SY, Park JC, Mook-Jung I (2014b) Ab1\u201342 reduces P-glycoprotein in the blood\u2013brain barrier through RAGE\u2013NF-\u03baB signaling. Cell Death Dis 5:e1299","journal-title":"Cell Death Dis"},{"key":"9_CR270","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1046\/j.1471-4159.2001.00112.x","volume":"76","author":"JK Parks","year":"2001","unstructured":"Parks JK, Smith TS, Trimmer PA, Bennett JP Jr, Parker WD Jr (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem 76:1050\u20131056","journal-title":"J Neurochem"},{"key":"9_CR271","doi-asserted-by":"publisher","first-page":"10094","DOI":"10.1523\/JNEUROSCI.3382-05.2005","volume":"25","author":"R Polavarapu","year":"2005","unstructured":"Polavarapu R, Gongora MC, Winkles JA, Yepes M (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25:10094\u201310100","journal-title":"J Neurosci"},{"key":"9_CR272","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/mp1003898","volume":"8","author":"B Poller","year":"2011","unstructured":"Poller B, Wagenaar E, Tang SC, Schinkel AH (2011) Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier. Mol Pharm 8:571\u2013582","journal-title":"Mol Pharm"},{"key":"9_CR273","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1124\/dmd.108.024646","volume":"37","author":"JW Polli","year":"2009","unstructured":"Polli JW, Olson KL, Chism JP, John-Williams LS, Yeager RL, Woodard SM et al (2009) An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2- (methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016). Drug Metab Dispos 37:439\u2013442","journal-title":"Drug Metab Dispos"},{"key":"9_CR274","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1124\/jpet.103.049858","volume":"306","author":"H Potschka","year":"2003","unstructured":"Potschka H, Fedrowitz M, L\u00f6scher W (2003) Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. J Pharmacol Exp Ther 306:124\u2013131","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR275","first-page":"125","volume":"2","author":"S Prasad","year":"2014","unstructured":"Prasad S, Sajja RK, Naik P, Cucullo L (2014) Diabetes mellitus and blood-brain barrier dysfunction: an overview. J Pharmacovigil 2:125","journal-title":"J Pharmacovigil"},{"key":"9_CR276","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.stemcr.2017.03.003","volume":"8","author":"K Qian","year":"2017","unstructured":"Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming GL et al (2017) Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Rep 8:843\u2013855","journal-title":"Stem Cell Rep"},{"key":"9_CR277","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2012-120319","volume":"31","author":"A Qosa","year":"2012","unstructured":"Qosa A, Abuznait AH, Hill RH, Kaddoumi A (2012) Enhanced Brain Amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer\u2019s Disease. J Alzheimers Dis 31:151\u2013165","journal-title":"J Alzheimers Dis"},{"key":"9_CR278","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1021\/acschemneuro.5b00190","volume":"6","author":"H Qosa","year":"2015","unstructured":"Qosa H, Batarseh YS, Mohyeldin MM, El Sayed KA, Keller JN, Kaddoumi A (2015a) Oleocanthal enhances amyloid-\u03b2 clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci 6:1849\u20131859","journal-title":"ACS Chem Neurosci"},{"key":"9_CR279","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","volume":"1628","author":"H Qosa","year":"2015","unstructured":"Qosa H, Miller DS, Pasinelli P, Trotti D (2015b) Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res 1628:298\u2013316","journal-title":"Brain Res"},{"key":"9_CR280","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2010.10.024","volume":"68","author":"A Quaegebeur","year":"2010","unstructured":"Quaegebeur A, Segura I, Carmeliet P (2010) Pericytes: blood-brain barrier safeguards against neurodegeneration? Neuron 68:321\u2013323","journal-title":"Neuron"},{"key":"9_CR281","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1528-1167.2012.03405.x","volume":"53","author":"A Raabe","year":"2012","unstructured":"Raabe A, Schmitz AK, Pernhorst K, Grote A, von der Brelie C, Urbach H et al (2012) Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions. Epilepsia 53:539\u2013548","journal-title":"Epilepsia"},{"key":"9_CR282","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Redzic","year":"2011","unstructured":"Redzic (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8:3","journal-title":"Fluids Barriers CNS"},{"key":"9_CR283","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS et al (2013) Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 309:1483\u20131492","journal-title":"JAMA"},{"key":"9_CR284","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/brain\/awm118","volume":"130","author":"V Rigau","year":"2007","unstructured":"Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P et al (2007) Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 130:1942\u20131956","journal-title":"Brain"},{"key":"9_CR285","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","volume":"69","author":"K Ritchie","year":"2007","unstructured":"Ritchie K, Carri\u00e8re I, de Mendonca A, Portet F, Dartigues JF, Rouaud O et al (2007) The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69:536\u2013545","journal-title":"Neurology"},{"key":"9_CR286","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","volume":"101","author":"I Rite","year":"2007","unstructured":"Rite I, Machado A, Cano J, Venero JL (2007) Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem 101:1567\u20131582","journal-title":"J Neurochem"},{"key":"9_CR287","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuroscience.2008.06.015","volume":"155","author":"LM Roberts","year":"2008","unstructured":"Roberts LM, Black DS, Raman C, Woodford K, Zhou M, Haggerty JE et al (2008) Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155:423\u2013438","journal-title":"Neuroscience"},{"key":"9_CR288","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","volume":"61","author":"RW Robey","year":"2009","unstructured":"Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M et al (2009) ABCG2: a perspective. Adv Drug Deliv Rev 61:3\u201313","journal-title":"Adv Drug Deliv Rev"},{"key":"9_CR289","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1124\/jpet.110.174151","volume":"336","author":"PT Ronaldson","year":"2011","unstructured":"Ronaldson PT, Finch JD, Demarco KM, Quigley CE, Davis TP (2011) Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. J Pharmacol Exp Ther 336:827\u2013839","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR290","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205\u2013216","journal-title":"Lancet Neurol"},{"key":"9_CR291","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","volume":"165","author":"M Roth","year":"2012","unstructured":"Roth M, Obaidat A, Hagenbuch B (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260\u20131287","journal-title":"Br J Pharmacol"},{"key":"9_CR292","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/WNL.0b013e3181d3e2dd","volume":"74","author":"RR Rule","year":"2010","unstructured":"Rule RR, Schuff N, Miller RG, Weiner MW (2010) Gray matter perfusion correlates with disease severity in ALS. Neuroloy 74:821\u2013827","journal-title":"Neuroloy"},{"key":"9_CR293","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/jnen\/63.5.418","volume":"63","author":"M Sadowski","year":"2004","unstructured":"Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH et al (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP\/PS1 mice. J Neuropathol Exp Neurol 63:418\u2013428","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR294","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","volume":"13","author":"A Sagare","year":"2007","unstructured":"Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R et al (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13:1029\u20131031","journal-title":"Nat Med"},{"key":"9_CR295","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011452","volume":"2","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2:pii: a011452","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9_CR296","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3233\/JAD-2012-129037","volume":"33","author":"AP Sagare","year":"2013","unstructured":"Sagare AP, Bell RD, Zlokovic BV (2013) Neurovascular defects and faulty amyloid-\u03b2 vascular clearance in Alzheimer\u2019s disease. J Alzheimers Dis 33:S87\u2013S100","journal-title":"J Alzheimers Dis"},{"key":"9_CR297","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1043-6618(03)00056-2","volume":"48","author":"D Sahin","year":"2003","unstructured":"Sahin D, Ilbay G, Ates N (2003) Changes in the blood-brain barrier permeability and in the brain tissue trace element concentrations after single and repeated pentylenetetrazole-induced seizures in rats. Pharmacol Res 48:69\u201373","journal-title":"Pharmacol Res"},{"key":"9_CR298","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","volume":"36","author":"N Sakae","year":"2016","unstructured":"Sakae N, Liu CC, Shinohara M, Frisch-Daiello J, Ma L, Yamazaki Y et al (2016) ABCA7 deficiency accelerates amyloid-\u03b2 generation and Alzheimer\u2019s neuronal pathology. J Neurosci 36:3848\u20133859","journal-title":"J Neurosci"},{"key":"9_CR1004","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/epi.12713","volume":"55","author":"S Salar","year":"2014","unstructured":"Salar S, Maslarova A, Lippmann K, Nichtweiss J, Weissberg I, Sheintuch L et al (2014) Blood-brain barrier dysfunction can contribute to pharmacoresistance of seizures. Epilepsia 55:1255\u20131263. https:\/\/doi.org\/10.1111\/epi.12713","journal-title":"Epilepsia"},{"key":"9_CR299","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2174\/13816128113199990463","volume":"20","author":"L Sanchez-Covarrubias","year":"2014","unstructured":"Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT (2014) Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des 20:1422\u20131449","journal-title":"Curr Pharm Des"},{"key":"9_CR300","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.112.199786","volume":"345","author":"R Sane","year":"2013","unstructured":"Sane R, Agarwal S, Mittapalli RK, Elmquist WF (2013) Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system. J Pharmacol Exp Ther 345:111\u2013124","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR301","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/neup.12221","volume":"35","author":"S Sasaki","year":"2015","unstructured":"Sasaki S (2015) Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis. Neuropathology 35:518\u2013528","journal-title":"Neuropathology"},{"key":"9_CR302","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0006-8993(00)03075-4","volume":"888","author":"N Sasaki","year":"2001","unstructured":"Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y et al (2001) Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer\u2019s disease. Brain Res 888:256\u2013262","journal-title":"Brain Res"},{"key":"9_CR303","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.addr.2012.09.027","volume":"64","author":"AH Schinkel","year":"2012","unstructured":"Schinkel AH, Jonker JW (2012) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 64:138\u2013153","journal-title":"Adv Drug Deliv Rev"},{"key":"9_CR304","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel AH, Smit JJM, Vantellingen O, Beijnen JH, Wagenaar E, Vandeemter L et al (1994) Disruption of the mouse Mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain-barrier and to increased sensitivity to drugs. Cell 77:491\u2013502","journal-title":"Cell"},{"key":"9_CR305","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.seizure.2012.10.014","volume":"22","author":"AK Schmitz","year":"2013","unstructured":"Schmitz AK, Grote A, Raabe A, Urbach H, Friedman A, von Lehe M et al (2013) Albumin storage in neoplastic astroglial elements of gangliogliomas. Seizure 22:144\u2013150","journal-title":"Seizure"},{"key":"9_CR306","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/609202","volume":"2011","author":"Y Serlin","year":"2011","unstructured":"Serlin Y, Levy J, Shalev H (2011) Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc Psychiatry Neurol 2011:609202","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"9_CR307","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842","journal-title":"Nat Med"},{"key":"9_CR308","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/dom.12120","volume":"15","author":"B Shao","year":"2013","unstructured":"Shao B, Bayraktutan U (2013) Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-\u03b2. Diabetes Obes Metab 15:993\u2013999","journal-title":"Diabetes Obes Metab"},{"key":"9_CR309","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.redox.2014.05.005","volume":"2","author":"B Shao","year":"2014","unstructured":"Shao B, Bayraktutan U (2014) Hyperglycaemia promotes human brain microvascular endothelial cell apoptosis via induction of protein kinase C-\u00dfI and prooxidant enzyme NADPH oxidase. Redox Biol 2:694\u2013701","journal-title":"Redox Biol"},{"key":"9_CR310","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/mp200129p","volume":"8","author":"R Shawahna","year":"2011","unstructured":"Shawahna R, Uchida Y, Decl\u00e8ves X, Ohtsuki S, Yousif S, Dauchy S et al (2011) Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 8:1332\u20131341","journal-title":"Mol Pharm"},{"key":"9_CR311","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1471-4159.2010.06887.x","volume":"114","author":"S Shen","year":"2010","unstructured":"Shen S, Callaghan D, Juzwik C, Xiong H, Huang P, Zhang W (2010) ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer\u2019s disease. J Neurochem 114:1590\u20131604","journal-title":"J Neurochem"},{"key":"9_CR312","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C et al (2014) Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128:639\u2013650","journal-title":"Acta Neuropathol"},{"key":"9_CR313","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B et al (2000) Clearance of Alzheimer\u2019s amyloid-\u03b2 (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489\u20131499","journal-title":"J Clin Invest"},{"key":"9_CR314","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","volume":"69","author":"GD Silverberg","year":"2010","unstructured":"Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS et al (2010) Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol 69:1034\u20131043","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR316","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/jcbfm.2010.84","volume":"31","author":"DE Smith","year":"2011","unstructured":"Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF (2011) Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J Cereb Blood Flow Metab 31:250\u2013261","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR317","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neuroscience.2005.11.011","volume":"138","author":"A Soontornmalai","year":"2006","unstructured":"Soontornmalai A, Vlaming ML, Fritschy JM (2006) Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138:159\u2013169","journal-title":"Neuroscience"},{"key":"9_CR318","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nn1676","volume":"9","author":"A Spudich","year":"2006","unstructured":"Spudich A, Kilic E, Xing H, Kilic \u00dc, Rentsch KM, Wunderli-Allenspach H et al (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9:487\u2013488","journal-title":"Nat Neurosci"},{"key":"9_CR319","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr JM, Wardlaw J, Ferguson K, Mac Lullich A, Deary IJ, Marshall I (2003) Increased blood\u2013brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74:70\u201376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9_CR320","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-10-9","volume":"10","author":"D Stephan","year":"2013","unstructured":"Stephan D, Sbai O, Wen J, Couraud PO, Putterman C, Khrestchatisky M et al (2013) TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation 10:9","journal-title":"J Neuroinflammation"},{"key":"9_CR321","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ana.24618","volume":"79","author":"L Stoica","year":"2016","unstructured":"Stoica L, Todeasa SH, Cabrera GT, Salameh JS, ElMallah MK, Mueller C et al (2016) AAV delivered artificial microRNA extends survival and delays paralysis in an Amyotrophic Lateral Sclerosis mouse model. Ann Neurol 79:687\u2013700","journal-title":"Ann Neurol"},{"key":"9_CR322","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2990.2008.01005.x","volume":"35","author":"HB Stolp","year":"2009","unstructured":"Stolp HB, Dziegielewska KM (2009) Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 35:132\u2013146","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9_CR323","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"N Strazielle","year":"2013","unstructured":"Strazielle N, Ghersi-Egea JF (2013) Physiology of blood\u2212brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10:1473\u20131491","journal-title":"Mol Pharm"},{"key":"9_CR324","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/syn.21667","volume":"67","author":"W Su","year":"2013","unstructured":"Su W, Pasternak GW (2013) The role of multidrug resistance associated protein (Mrp) in the blood-brain barrier and opioid analgesia. Synapse 67:609\u2013619","journal-title":"Synapse"},{"key":"9_CR325","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA (2014) Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 62:197\u2013202","journal-title":"Peptides"},{"key":"9_CR326","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s11064-004-7028-0","volume":"29","author":"R Sultana","year":"2004","unstructured":"Sultana R, Butterfield DA (2004) Oxidatively modified GST and MRP1 in Alzheimer\u2019s disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem Res 29:2215\u20132220","journal-title":"Neurochem Res"},{"key":"9_CR327","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10571-009-9446-7","volume":"30","author":"N Sumi","year":"2010","unstructured":"Sumi N, Nishioku T, Takata F, Matsumoto J, Watanabe T, Shuto H et al (2010) Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell Mol Neurobiol 30:247\u2013253","journal-title":"Cell Mol Neurobiol"},{"key":"9_CR328","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1745-7254.2006.00246.x","volume":"27","author":"JJ Sun","year":"2006","unstructured":"Sun JJ, Xie L, Liu XD (2006) Transport of carbamazepine and drug interactions at blood-brain barrier. Acta Pharmacol Sin 27:249\u2013253","journal-title":"Acta Pharmacol Sin"},{"key":"9_CR330","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neulet.2004.09.046","volume":"372","author":"EK Tan","year":"2004","unstructured":"Tan EK, Drozdzik M, Bialecka M, Honczarenko K, Klodowska-Duda G, Teo YY et al (2004) Analysis of MDR1 haplotypes in Parkinson\u2019s disease in a white population. Neurosci Lett 372:240\u2013244","journal-title":"Neurosci Lett"},{"key":"9_CR331","first-page":"4600","volume":"62","author":"EK Tan","year":"2005","unstructured":"Tan EK, Chan DK, Ng PW, Woo J, Teo YY, Tang K et al (2005) Effect of MDR1 haplotype on risk of Parkinson disease. Arch Neurol 62:4600\u20134464","journal-title":"Arch Neurol"},{"key":"9_CR332","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120:545\u2013555","journal-title":"Cell"},{"key":"9_CR333","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/pedi.12153","volume":"15","author":"RC Tasker","year":"2014","unstructured":"Tasker RC, Acerini CL (2014) Cerebral edema in children with diabetic ketoacidosis: vasogenic rather than cellular? Pediatr Diabetes 15:261\u2013270","journal-title":"Pediatr Diabetes"},{"key":"9_CR334","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609","journal-title":"Acta Neuropathol"},{"key":"9_CR335","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/jcbfm.2014.4","volume":"34","author":"BJ Thompson","year":"2014","unstructured":"Thompson BJ, Sanchez-Covarrubias L, Slosky LM, Zhang Y, Laracuente ML, Ronaldson PT (2014) Hypoxia\/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp 1a4) at the blood-brain barrier: relevance to CNS drug delivery. J Cereb Blood Flow Metab 34:699\u2013707","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR336","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/CBB:43:1:037","volume":"43","author":"SC Tyagi","year":"2005","unstructured":"Tyagi SC, Lominadze D, Roberts AM (2005) Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys 43:37\u201344","journal-title":"Cell Biochem Biophys"},{"key":"9_CR337","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","volume":"117","author":"Y Uchida","year":"2011","unstructured":"Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J et al (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333\u2013345","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"9_CR338","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DM Assema van","year":"2012","unstructured":"van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD et al (2012) Blood-brain barrier P-glycoprotein function in Alzheimer\u2019s disease. Brain 135(Pt 1):181\u2013189","journal-title":"Brain"},{"key":"9_CR339","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1289\/ehp.1103881","volume":"120","author":"M Mark van der","year":"2012","unstructured":"van der Mark M, Brouwer M, Kromhout H, Nijssen P, Huss A, Vermeulen R (2012) Is pesticide use related to Parkinson disease? some clues to heterogeneity in study results. Environ Health Perspect 120:340\u2013347","journal-title":"Environ Health Perspect"},{"key":"9_CR340","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","volume":"61","author":"BM Gelder van","year":"2007","unstructured":"van Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, Nissinen A et al (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study. Eur J Clin Nutr 61:226\u2013232","journal-title":"Eur J Clin Nutr"},{"key":"9_CR341","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awl318","volume":"130","author":"EA Vliet Van","year":"2007","unstructured":"Van Vliet EA, Da C, Araujo S, Redeker S, Van Schaik R, Aronica E et al (2007) Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130:521\u2013534","journal-title":"Brain"},{"key":"9_CR342","doi-asserted-by":"publisher","first-page":"199","DOI":"10.18433\/J3B596","volume":"12","author":"S Vautier","year":"2009","unstructured":"Vautier S, Milane A, Fernandez C, Chacun H, Lacomblez L, Farinotti R (2009) Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration. J Pharm Pharm Sci 12:199\u2013208","journal-title":"J Pharm Pharm Sci"},{"key":"9_CR343","first-page":"332","volume":"11","author":"MS Vavilala","year":"2010","unstructured":"Vavilala MS, Richards TL, Roberts JS, Chiu H, Pihoker C, Bradford H et al (2010) Change in blood\u2013 brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med 11:332\u2013338","journal-title":"Pediatr Crit Care Med"},{"key":"9_CR344","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.0587-16.2016","volume":"36","author":"U Vazana","year":"2016","unstructured":"Vazana U, Veksler R, Pell GS, Prager O, Fassler M, Chassidim Y et al (2016) Glutamate-mediated blood\u2013brain barrier opening: implications for neuroprotection and drug delivery. J Neurosci 36:7727\u20137739","journal-title":"J Neurosci"},{"key":"9_CR345","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuro.2009.02.011","volume":"30","author":"RF Villar\u00e1n","year":"2009","unstructured":"Villar\u00e1n RF, de Pablos RM, Arg\u00fcelles S, Espinosa-Oliva AM, Tom\u00e1s-Camardiel M et al (2009) The intranigral injection of tissue plasminogen activator induced blood-brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat. Neurotoxicology 30:403\u2013413","journal-title":"Neurotoxicology"},{"key":"9_CR346","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/brb3.143","volume":"3","author":"S Vinsant","year":"2013","unstructured":"Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo Moore V, Yoshikawa M, Hampton TG et al (2013) Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav 3:335\u2013350","journal-title":"Brain Behav"},{"key":"9_CR347","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM (2011) Cerebral amyloid angiopathy (CAA) in the elderly. Ann Neurol 70:871\u2013880","journal-title":"Ann Neurol"},{"key":"9_CR348","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","volume":"12","author":"S Vogelgesang","year":"2002","unstructured":"Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W et al (2002) Deposition of Alzheimer\u2019s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535\u2013541","journal-title":"Pharmacogenetics"},{"key":"9_CR349","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1567205043332225","volume":"1","author":"S Vogelgesang","year":"2004","unstructured":"Vogelgesang S, Warzok RW, Cascorbi I, Kunert-Keil C, Schroeder E, Kroemer HK et al (2004) The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 1:121\u2013125","journal-title":"Curr Alzheimer Res"},{"key":"9_CR350","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD et al (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279:40987\u201340993","journal-title":"J Biol Chem"},{"key":"9_CR351","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM et al (2005) Deletion of Abca 1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem 280:43236\u201343242","journal-title":"J Biol Chem"},{"key":"9_CR352","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A et al (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118:671\u2013682","journal-title":"J Clin Invest"},{"key":"9_CR353","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/13543784.2015.1001490","volume":"24","author":"D Walker","year":"2015","unstructured":"Walker D, Lue LF, Paul G, Patel A, Sabbagh MN (2015) Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer\u2019s disease. Expert Opin Investig Drugs 24:393\u2013399","journal-title":"Expert Opin Investig Drugs"},{"key":"9_CR354","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/oemed-2013-101394","volume":"71","author":"A Wang","year":"2014","unstructured":"Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B (2014) The association between ambient exposure to organophosphates and Parkinson\u2019s disease risk. Occup Environ Med 71:275\u2013281","journal-title":"Occup Environ Med"},{"key":"9_CR355","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2174\/1567205013666160314151012","volume":"13","author":"W Wang","year":"2016","unstructured":"Wang W, Bodles-Brakhop AM, Barger SW (2016) A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid \u03b2 -Peptide from the Brain. Curr Alzheimer Res 13:615\u2013620","journal-title":"Curr Alzheimer Res"},{"key":"9_CR356","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.phrs.2009.02.007","volume":"59","author":"MS Warren","year":"2009","unstructured":"Warren MS, Zerangue N, Woodford K, Roberts LM, Tate EH, Feng B et al (2009) Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 59:404\u2013413","journal-title":"Pharmacol Res"},{"key":"9_CR357","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","volume":"1788","author":"N Weiss","year":"2009","unstructured":"Weiss N, Miller F, Cazaubon S, Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842\u2013857","journal-title":"Biochim Biophys Acta"},{"key":"9_CR358","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.02.029","volume":"78","author":"I Weissberg","year":"2015","unstructured":"Weissberg I, Wood L, Kamintsky L, Vazquez O, Milikovsky DZ, Alexander A et al (2015) Albumin induces excitatory synaptogenesis through astrocytic TGF-\u03b2\/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction. Neurobiol Dis 78:115\u2013125","journal-title":"Neurobiol Dis"},{"key":"9_CR359","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2008.02.016","volume":"270","author":"T Wen","year":"2008","unstructured":"Wen T, Liu YC, Yang HW, Liu HY, Liu XD, Wang GJ et al (2008) Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain. J Neurol Sci 270:99\u2013106","journal-title":"J Neurol Sci"},{"key":"9_CR360","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.parkreldis.2008.11.010","volume":"15","author":"M Westerlund","year":"2009","unstructured":"Westerlund M, Belin AC, Anvret A, H\u00e5kansson A, Nissbrandt H, Lind C et al (2009) Association of a polymorphism in the ABCB1 gene with Parkinson\u2019s disease. Parkinsonism Relat Disord 15:422\u2013424","journal-title":"Parkinsonism Relat Disord"},{"key":"9_CR361","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","volume":"1358","author":"HC Wijesuriya","year":"2010","unstructured":"Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA (2010) ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects. Brain Res 1358:228\u2013238","journal-title":"Brain Res"},{"key":"9_CR362","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2005.07.078","volume":"1058","author":"MJ Williams","year":"2005","unstructured":"Williams MJ, Lowrie MB, Bennett JP, Firth JA, Clark P (2005) Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse. Brain Res 1058:62\u201372","journal-title":"Brain Res"},{"key":"9_CR363","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nn.2946","volume":"14","author":"EA Winkler","year":"2011","unstructured":"Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14:1398\u20131405","journal-title":"Nat Neurosci"},{"key":"9_CR364","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/jcbfm.2012.113","volume":"32","author":"EA Winkler","year":"2012","unstructured":"Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV (2012) Blood\u2013spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab 32:1841\u20131852","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR365","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","volume":"125","author":"EA Winkler","year":"2013","unstructured":"Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV (2013) Blood\u2013spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125:111\u2013120","journal-title":"Acta Neuropathol"},{"key":"9_CR366","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","volume":"111","author":"EA Winkler","year":"2014","unstructured":"Winkler EA, Sengillo JD, Sagare AP, Zhao Z, Ma Q, Zuniga E et al (2014) Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci USA 111:E1035\u2013E1042","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR367","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D et al (2015) GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18:521\u2013530","journal-title":"Nat Neurosci"},{"key":"9_CR368","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/pr.2015.215","volume":"79","author":"M Woo","year":"2016","unstructured":"Woo M, Patterson EK, Cepinskas G, Clarson C, Omatsu T, Fraser DD (2016a) Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis. Pediatr Res 79:295\u2013300","journal-title":"Pediatr Res"},{"key":"9_CR369","doi-asserted-by":"publisher","first-page":"e846","DOI":"10.1097\/CCM.0000000000001720","volume":"44","author":"MM Woo","year":"2016","unstructured":"Woo MM, Patterson EK, Clarson C, Cepinskas G, Bani-Yaghoub M, Stanimirovic DB et al (2016b) Elevated leukocyte azurophilic enzymes in human diabetic ketoacidosis plasma degrade cerebrovascular endothelial junctional proteins. Crit Care Med 44:e846\u2013e853","journal-title":"Crit Care Med"},{"key":"9_CR370","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jcbfm.2014.162","volume":"35","author":"KC Wu","year":"2015","unstructured":"Wu KC, Lu YH, Peng YH, Tsai TF, Kao YH, Yang HT et al (2015) Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice. J Cereb Blood Flow Metab 35:37\u201347","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR371","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","volume":"29","author":"H Xiong","year":"2009","unstructured":"Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C et al (2009) ABCG2 is upregulated in Alzheimer\u2019s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1\u221240) peptides. J Neurosci 29:5463\u20135475","journal-title":"J Neurosci"},{"key":"9_CR372","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brainres.2010.11.056","volume":"1372","author":"R Xu","year":"2011","unstructured":"Xu R, Wu C, Zhang X, Zhang Q, Yang Y, Yi J, Yang R, Tao Y (2011) Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res 1372:133\u2013144","journal-title":"Brain Res"},{"key":"9_CR373","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH et al (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251\u2013253","journal-title":"Nat Neurosci"},{"key":"9_CR374","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.eplepsyres.2007.10.006","volume":"78","author":"ZH Yang","year":"2008","unstructured":"Yang ZH, Liu XD (2008) P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro. Epilepsy Res 78:40\u201349","journal-title":"Epilepsy Res"},{"key":"9_CR375","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697\u2013709","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR376","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neulet.2008.01.071","volume":"434","author":"HW Yang","year":"2008","unstructured":"Yang HW, Liu HY, Liu X, Zhang DM, Liu YC, Liu XD et al (2008) Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro. Neurosci Lett 434:299\u2013303","journal-title":"Neurosci Lett"},{"key":"9_CR377","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mvr.2008.11.003","volume":"77","author":"B Yang","year":"2009","unstructured":"Yang B, Akhter S, Chaudhuri A, Kanmogne GD (2009) HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc Res 77:212\u2013219","journal-title":"Microvasc Res"},{"key":"9_CR378","first-page":"201","volume":"4","author":"JJ Yang","year":"2010","unstructured":"Yang JJ, Milton MN, Yu S, Liao M, Liu N, Wu JT et al (2010) P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor. Drug Metab Lett 4:201\u2013212","journal-title":"Drug Metab Lett"},{"key":"9_CR379","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-2011-110725","volume":"27","author":"J Yang","year":"2011","unstructured":"Yang J, Lunde LK, Nuntagij P, Oguchi T, Camassa LM, Nilsson LN et al (2011) Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer\u2019s\u2019s disease. J Alzheimers Dis 27:711\u2013722","journal-title":"J Alzheimers Dis"},{"key":"9_CR380","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00210-011-0609-y","volume":"383","author":"D Yao","year":"2011","unstructured":"Yao D, Yang ZH, Liu L, Li J, Yu YL, Zhang LL et al (2011) Verapamil exerts biphasic modulation on phenobarbital transport across the blood-brain barrier: evidence from an in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol 383:393\u2013402","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9_CR381","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuroscience.2012.10.006","volume":"227","author":"D Yao","year":"2012","unstructured":"Yao D, Liu L, Jin S, Li J, Liu XD (2012) Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats. Neuroscience 227:283\u2013292","journal-title":"Neuroscience"},{"key":"9_CR382","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/jns.2004.101.2.0303","volume":"101","author":"D Yarnitsky","year":"2004","unstructured":"Yarnitsky D, Gross Y, Lorian A, Shalev A, Lamensdorf I, Bornstein R et al (2004) Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain. J Neurosur 101:303\u2013309","journal-title":"J Neurosur"},{"key":"9_CR383","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12011-012-9546-y","volume":"151","author":"H Yorulmaz","year":"2013","unstructured":"Yorulmaz H, \u015eeker FB, Demir G, Yal\u00e7\u0131n \u012cE, \u00d6zta\u015f B (2013) The effects of zinc treatment on the blood-brain barrier permeability and brain element levels during convulsions. Biol Trace Elem Res 151:256\u2013262","journal-title":"Biol Trace Elem Res"},{"key":"9_CR384","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1050-1738(01)00149-9","volume":"12","author":"Z Zhang","year":"2002","unstructured":"Zhang Z, Chopp M (2002) Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 12:62\u201366","journal-title":"Trends Cardiovasc Med"},{"key":"9_CR385","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1124\/jpet.104.068528","volume":"311","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Schuetz JD, Elmquist WF, Miller DW (2004) Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J Pharmacol Exp Ther 311:449\u2013455","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR386","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2007.01.133","volume":"1144","author":"H Zhang","year":"2007","unstructured":"Zhang H, Gu YT, Xue YX (2007) Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5\u2032-triphosphate-sensitive potassium channel. Brain Res 1144:33\u201341","journal-title":"Brain Res"},{"key":"9_CR387","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbr.2011.03.072","volume":"222","author":"W Zhang","year":"2011","unstructured":"Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C et al (2011) Soluble A\u03b2 levels correlate with cognitive deficits in the 12-month-old APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Behav Brain Res 222:342\u2013350","journal-title":"Behav Brain Res"},{"key":"9_CR388","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM (2007) TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 26:36\u201346","journal-title":"Neurobiol Dis"},{"key":"9_CR389","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1124\/dmd.108.025064","volume":"37","author":"R Zhao","year":"2009","unstructured":"Zhao R, Raub TJ, Sawada GA, Kasper SC, Bacon JA, Bridges AS, Pollack GM (2009) Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier. Drug Metab Dispos 37:1251\u20131258","journal-title":"Drug Metab Dispos"},{"key":"9_CR390","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","volume":"11","author":"Z Zhong","year":"2008","unstructured":"Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O\u2019Banion MK et al (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11:420\u2013422","journal-title":"Nat Neurosci"},{"key":"9_CR391","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1124\/dmd.108.024489","volume":"37","author":"L Zhou","year":"2009","unstructured":"Zhou L, Schmidt K, Nelson FR, Zelesky V, Troutman MD, Feng B (2009) The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4- yl)ethoxy)phenyl) propanoic acid (PF-407288) in mice. Drug Metab Dispos 37:946\u2013955","journal-title":"Drug Metab Dispos"},{"key":"9_CR392","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1215\/15228517-2008-067","volume":"11","author":"JJ Zhu","year":"2009","unstructured":"Zhu JJ, Gerstner ER, Engler DA, Mrugala MM, Nugent W, Nierenberg K et al (2009) High-dose methotrexate for elderly patients with primary CNS lymphoma. Neuro Oncol 11:211\u2013215","journal-title":"Neuro Oncol"},{"key":"9_CR393","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1158\/0008-5472.CAN-06-0929","volume":"66","author":"Y Zhuang","year":"2006","unstructured":"Zhuang Y, Fraga CH, Hubbard KE, Hagedorn N, Panetta JC, Waters CM et al (2006) Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor. Cancer Res. 66:11305\u201311313","journal-title":"Cancer Res."},{"key":"9_CR394","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00415-009-0089-x","volume":"256","author":"K Zschiedrich","year":"2009","unstructured":"Zschiedrich K, K\u00f6nig IR, Br\u00fcggemann N, Kock N, Kasten M, Leenders KL et al (2009) MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol 256:115\u2013120","journal-title":"J Neurol"}],"container-title":["Advances in Experimental Medicine and Biology","Drug Transporters in Drug Disposition, Effects and Toxicity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7647-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:42:03Z","timestamp":1611434523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-7647-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811376467","9789811376474"],"references-count":393,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7647-4_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"1 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}